- Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo; Drug: Placebo; Drug: Sirukumab; Drug: Sirukumab; Drug: Sirukumab
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Not yet recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis Associated Uveitis
Intervention: Drug: Tocilizumab
Sponsors: Oregon Health and Science University; Eric B. Suhler; Genentech
Not yet recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: anti-TNF withdrawal (tanercept, adalimumab, infliximab, certolizumab, golimumab)
Sponsors: Medical University of Graz; Medical University of Graz
Not yet recruiting - verified May 2012 - Condition: Foot Diseases
Intervention:
Sponsors: eMedtrain Inc.; eMedtrain Inc.
Recruiting - verified May 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: JNJ-40346527; Drug: Placebo
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Not yet recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention: Drug: Shinbaro Capsule
Sponsors: Green Cross Corporation; Green Cross Corporation
Recruiting - verified May 2012 - Conditions: Rheumatoid Arthritis; Systemic Vasculitis
Intervention: Other: Resistance Exercise
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified May 2012 - Condition: Acute Gouty Arthritis
Interventions: Drug: ACZ885; Drug: Triamcinelone acetonide
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Knee Osteoarthritis
Interventions: Other: Mobility shoe; Other: control shoe
Sponsors: Rush University Medical Center; Rush University Medical Center; Arthritis Foundation
Recruiting - verified May 2012 - Condition: Graft Versus Host Disease
Intervention: Drug: Cannabidiol
Sponsors: Rabin Medical Center; Rabin Medical Center
Not yet recruiting - verified May 2012 - Condition: Glioblastoma
Interventions: Drug: Hydroxychloroquine; Radiation: Radiotherapy
Sponsors: University College, London; University College, London; Cancer Research UK
Not yet recruiting - verified May 2012 - Conditions: Axial and Peripheral Spondyloarthritis; Rheumatoid Arthritis
Interventions: Drug: administration of Cimzia®; Drug: Immunoscintigraphy with radiolabeled Cimzia®.
Sponsors: University Hospital, Ghent; University Hospital, Ghent; UCB Pharma SA
Not yet recruiting - verified May 2012 - Condition: Hip and Knee Osteoarthritis
Intervention: Other: Procedural, Bone Marrow concentrate injection
Sponsors: Regenerative Pain Center, Illinois; Regenerative Pain Center, Illinois
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: VX-509; Drug: VX-509 matching placebo
Sponsors: Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals Incorporated
Recruiting - verified May 2012 - Condition: Knee Osteoarthritis
Interventions: Drug: SAR113945; Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University; Arthritis Foundation
Not yet recruiting - verified April 2012 - Conditions: Muscle Atrophy; ACL Reconstruction; Trauma; Osteoarthritis
Interventions: Drug: Testosterone; Drug: Saline
Sponsors: University of Southern California; University of Southern California; Boston University; University of Oregon
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: No Intervention (subjects were previously treated with Orencia®)
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Not yet recruiting - verified April 2012 - Condition: Carpal Tunnel Syndrome
Intervention: Device: EMS Therasonic 460 Primo Ultrasound therapy
Sponsors: East Kent Hospitals University NHS Foundation Trust; East Kent Hospitals University NHS Foundation Trust
Not yet recruiting - verified May 2012 - Conditions: Autoimmune Diseases; Sjogren's Syndrome; Dry Eye
Interventions: Drug: Hydroxychloroquine; Drug: Placebo
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche; Clalit Health Services
Not yet recruiting - verified May 2012 - Condition: Inflammatory Joint Diseases
Intervention:
Sponsors: Diakonhjemmet Hospital; Diakonhjemmet Hospital; University Hospital of North Norway; St. Olavs Hospital; Lillehammer Hospital for Rheumatic Diseases; Vestre Viken HF Drammen Hospital
Recruiting - verified April 2012 - Condition: Arterial Calcification Due to CD73-Deficiency (ACDC)
Interventions: Drug: Etidronate; Procedure: MRI; Procedure: CT Scan; Procedure: ABI; Procedure: Treadmill; Procedure: Dexa Scan; Procedure: Hand X-ray
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Ankylosing Spondyloarthritis
Interventions: Drug: Apremilast tablet 20 mg; Drug: Apremilast tablet 30 mg BID; Drug: Placebo
Sponsors: Celgene Corporation; Celgene Corporation
Recruiting - verified May 2012 - Condition: Osteoarthritis
Interventions: Other: Hospital Inpatient Rehabilitation; Other: Hybrid Home Programme (HO)
Sponsors: South West Sydney Local Health District; Mark Buhagiar; HammondCare
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: placebo
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Crohn's Disease
Intervention:
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Knee Osteoarthritis
Intervention: Other: Ultrasound guided femoral nerve block catheter analgesia compared with epidural analgesia for patients with knee OA (osteoarthritis)
Sponsors: King Saud University; King Saud University
Recruiting - verified February 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: RoActemra/Actemra (tocilizumab)
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Distal Radius Fracture
Interventions: Procedure: Open Reduction and Internal Fixation; Procedure: External Fixation; Procedure: Percutaneous Pinning; Procedure: Closed Reduction and casting
Sponsors: University of Michigan; University of Michigan; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: LY2127399
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Not yet recruiting - verified May 2012 - Condition: Cardiovascular Function
Intervention: Biological: Typhoid vaccine
Sponsors: Queen Mary University of London; Queen Mary University of London
Recruiting - verified April 2012 - Conditions: Osteoarthritis, Knee; Knee Arthrosis; Knee Osteoarthritis
Interventions: Other: Injection of Mesenchymal Stromal Cells; Drug: Hyaluronic Acid
Sponsors: Red de Terapia Celular; Red de Terapia Celular; Scientific Park Foundation, University of Valladolid; Instituto de Biologia y Genetica Molecular (IBGM), University of Valladolid; Sanidad de Castilla y Leon (SACYL); Centro Medico Teknon
Recruiting - verified April 2012 - Condition: Osteoarthritis
Intervention: Drug: Hylan G-F 20 (Synvisc)
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified April 2012 - Conditions: Chemical Injuries; Unspecified Complication of Corneal Transplant; Autoimmune Diseases; Ocular Cicatricial Pemphigoid; Stevens Johnson Syndrome; Lupus Erythematosus, Systemic; Rheumatoid Arthritis; Other Autoimmune Diseases
Intervention: Drug: Riboflavin
Sponsors: Massachusetts Eye and Ear Infirmary; Massachusetts Eye and Ear Infirmary
Recruiting - verified April 2012 - Condition: Ankylosing Spondylitis
Interventions: Other: aerobic training; Other: Stretching exercises
Sponsors: Federal University of São Paulo; Federal University of São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified April 2012 - Conditions: Back Pain; Osteoarthritis
Interventions: Other: Opioid-intensive prescribing strategy; Other: Opioid-avoidant prescribing strategy
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified April 2012 - Conditions: Osteoarthritis (OA); Rheumatoid Arthritis (RA); Ankylosing Spondylitis (AS)
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib; Drug: Fostamatinib; Drug: Fostamatinib; Drug: Fostamatinib; Drug: Placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: MK-8457 100 mg; Drug: MK-8457 100 mg; Drug: Dose-Matched Placebo; Drug: MK-8457 200 mg; Drug: MK-8457 25 mg; Drug: MK-8457
Sponsors: Merck; Merck
Not yet recruiting - verified April 2012 - Condition: Cardiovascular Check-up in Patients With Rheumatoid Arthritis
Intervention: Other: Cardiovascular check-up
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified March 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: ASP015K; Drug: Placebo
Sponsors: Astellas Pharma Inc; Astellas Pharma Global Development, Inc.
Not yet recruiting - verified May 2012 - An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified May 2012 - Condition: Recurrent or Tophacous Gout
Interventions: Other: Control; Other: Gout Disease Management Program
Sponsors: Kaiser Permanente; Kaiser Permanente
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: fostamatinib; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Infliximab; Biological: Infliximab
Sponsors: Nichi-Iko Pharmaceutical Co.,Ltd.; Nichi-Iko Pharmaceutical Co.,Ltd.
Recruiting - verified March 2012 - Condition: Cytokine Response to Vagus Nerve Stimulation
Intervention: Device: Vagus Nerve Stimulator
Sponsors: North Shore Long Island Jewish Health System; North Shore Long Island Jewish Health System
Recruiting - verified March 2012 - Conditions: Inflammation; Rheumatoid Arthritis
Interventions: Drug: NNC0114-0006; Drug: placebo
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Adalimumab; Drug: Current adalimumab
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Conditions: Hallux Valgus; Arthritis of the First Metatarsophalangeal Joint
Intervention: Procedure: skin preparation
Sponsors: St. Antonius Hospital; St. Antonius Hospital
Not yet recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: 800 mg ibuprofen/26.6 mg famotidine
Sponsors: Horizon Pharma, Inc.; Horizon Pharma, Inc.; Pediatric Rheumatology Collaborative Study Group
Not yet recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: MEDI5117; Biological: MEDI5117 Placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified May 2012 - Condition: Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott; CATO Research Canada; JSS Medical Research Inc.
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Tocilizumab, Abatacept; Drug: Tocilizumab, Abatacept
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Ministry of Health, France
Not yet recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Folic Acid; Drug: Placebo
Sponsors: Postgraduate Institute of Medical Education and Research; Postgraduate Institute of Medical Education and Research
Recruiting - verified April 2012 - Conditions: Greater Trochanteric Pain Syndrome; Hip Pain
Interventions: Device: Topaz; Procedure: Iliotibial band release and trochanteric bursectomy
Sponsors: ArthroCare Corporation; ArthroCare Corporation
Not yet recruiting - verified February 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Givinostat
Sponsors: Italfarmaco; Italfarmaco; Parexel
Recruiting - verified March 2012 - Condition: Spondylitis, Ankylosing
Intervention:
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified April 2012 - Conditions: Shoulder Capsulitis; Shoulder Adhesive Capsulitis; Frozen Shoulder
Interventions: Drug: Triamcinolone Acetonide; Drug: Triamcinolone Acetonide
Sponsors: University of Bergen; Satya Pal Sharma; Norwegian Medical Association
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Iguratimod
Sponsors: Jiangsu Simcere Pharmaceutical R&D Co. Ltd.; Jiangsu Simcere Pharmaceutical R&D Co. Ltd.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Knee Osteoarthritis
Interventions: Drug: Biofreeze; Other: Placebo
Sponsors: University of Chile; University of Chile
Not yet recruiting - verified March 2012 - Condition: Osteoarthritis Knee
Interventions: Procedure: Standardized Acupuncture; Procedure: sham acupuncture; Procedure: Individualized Acupuncture; Other: Waiting
Sponsors: DongGuk University; Eun Jung Kim; Chung-Joo Hospital of Oriental medicine, Semyung University; Ministry of Health & Welfare, Korea
Recruiting - verified April 2012 - Conditions: Osteoarthritis; Traumatic Osteoarthritis
Intervention: Device: iTotal KRS
Sponsors: ConforMIS, Inc.; ConforMIS, Inc.
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Device: Cyberonics VNS System
Sponsors: SetPoint Medical Corporation; SetPoint Medical Corporation
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Device: Cyberonics VNS System
Sponsors: SetPoint Medical Corporation; SetPoint Medical Corporation
Recruiting - verified March 2012 - Condition: Knee Osteoarthritis
Intervention: Device: Custom guides
Sponsors: University of Lausanne Hospitals; University of Lausanne Hospitals
Recruiting - verified April 2012 - Conditions: Scleroderma, Systemic; Sclerosis, Systemic; Systemic Scleroderma; Systemic Sclerosis
Interventions: Drug: Pomalidomide (CC-4047); Drug: Placebo
Sponsors: Celgene Corporation; Celgene Corporation
Not yet recruiting - verified April 2012 - Condition: Juvenile Idiopathic Arthritis (JIA)
Intervention: Drug: Certolizumab Pegol (CZP)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Triple Therapy; Drug: TNF inhibitors
Sponsors: Columbia University; Columbia University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified March 2012 - Conditions: Osteoarthritis; Traumatic Arthritis; Total Knee Joint Prosthesis
Intervention: Device: 3DKnee™ System with Vitamin E UHMWPE Tibial Inserts
Sponsors: Encore Medical, L.P.; Encore Medical, L.P.; DJO Incorporated
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Iguratimod; Drug: Methotrexate
Sponsors: Jiangsu Simcere Pharmaceutical R&D Co. Ltd.; Jiangsu Simcere Pharmaceutical R&D Co. Ltd.
Recruiting - verified May 2012 - Condition: Osteoarthritis
Interventions: Biological: Autologous adipose derived stem cells administrated for intra-articular use; Biological: Autologous adipose derived stem cells administrated for intra-articular use
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier
Recruiting - verified April 2012 - Condition: Arthritis, Rheumatoid
Interventions: Other: Supervised high-intensity exercise programme; Other: Exercise programme
Sponsors: Aarhus University Hospital; Aarhus University Hospital
Recruiting - verified March 2012 - Condition: Osteoarthritis
Interventions: Drug: duloxetine; Drug: sugar pill
Sponsors: Northwestern University; Northwestern University; Eli Lilly and Company
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Other: insoles intervention; Other: placebo insole
Sponsors: Federal University of São Paulo; Federal University of São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified March 2012 - Conditions: Osteoarthritis; Postoperative Pain
Intervention: Genetic: Whole blood for genotyping
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institutes of Health (NIH); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified March 2012 - Condition: Osteoarthritis
Intervention:
Sponsors: Northwestern University; Northwestern University; ZARS Pharma Inc.
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Gruppo Italiano Studio Early Arthritis; Gruppo Italiano Studio Early Arthritis
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Coxarthrosis
Interventions: Procedure: Direct lateral approach in total hip arthroplasty; Procedure: Anterior approach
Sponsors: Sorlandet Hospital HF; Sorlandet Hospital HF
Recruiting - verified April 2012 - Condition: Osteoarthritis, Knee
Interventions: Device: hylan G-F 20; Device: 1% sodium hyaluronate
Sponsors: American Orthopaedic Society for Sports Medicine; American Orthopaedic Society for Sports Medicine; United States Naval Medical Center, Portsmouth
Recruiting - verified March 2012 - Condition: Osteoarthritis of the Knee
Interventions: Drug: AF-219; Drug: Sugar Pill
Sponsors: Afferent Pharmaceuticals, Inc.; Afferent Pharmaceuticals, Inc.
Recruiting - verified April 2012 - Condition: Osteoarthritis of the Knee
Interventions: Drug: Etoricoxib 30 mg; Drug: Celecoxib 200 mg
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention: Other: implant fixation with different techniques and designs
Sponsors: Regional Hospital Holstebro; Regional Hospital Holstebro
Recruiting - verified March 2012 - Condition: Bicompartmental Osteoarthritis
Interventions: Device: ConforMIS iDuo G2; Device: Standard Total Knee Implant
Sponsors: ConforMIS, Inc.; ConforMIS, Inc.
Not yet recruiting - verified March 2012 - Condition: Sjögren's Syndrome
Interventions: Biological: Baminercept; Other: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: Web-based coping skills training; Behavioral: Online disease education
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not yet recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)
Sponsors: Alliancells Bioscience Corporation Limited; Alliancells Bioscience Corporation Limited
Not yet recruiting - verified March 2012 - Condition: Juvenile Idiopathic Arthritis (JIA)
Interventions: Drug: VIMOVO; Drug: VIMOVO; Drug: VIMOVO
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Condition: Anterior Cruciate Ligament Injury
Intervention: Other: Neuromuscular Electrical Stimulation
Sponsors: University of Michigan; University of Michigan; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified March 2012 - Condition: Degenerative Joint Disease of Hip and Knee.
Interventions: Drug: Placebo; Drug: Gapabentin
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey
Recruiting - verified March 2012 - Condition: Knee Osteoarthritis
Intervention: Other: Exercise
Sponsors: Frederiksberg University Hospital; Frederiksberg University Hospital
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: etanercept; Drug: methotrexate
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified April 2012 - Condition: Osteoarthritis
Intervention: Device: VANGUARD 360
Sponsors: Biomet, Inc.; Biomet, Inc.
Not yet recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified February 2012 - Condition: Osteoarthritis of the Shoulder
Interventions: Device: Zimmer TM Glenoid; Device: Cemented Glenoid
Sponsors: Joint Preservation Centre of BC; Joint Preservation Centre of BC
Not yet recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: rituximab
Sponsors: Celltrion; Celltrion
Not yet recruiting - verified February 2012 - Conditions: Scleroderma; Systemic Sclerosis; Diffuse Scleroderma; Diffuse Systemic Sclerosis
Interventions: Drug: Rilonacept; Drug: Placebo
Sponsors: Boston University; Boston University; Regeneron Pharmaceuticals
Recruiting - verified February 2012 - Condition: Osteoarthritis, Knee
Interventions: Drug: Naproxen; Drug: Placebo
Sponsors: Analgesic Solutions; Analgesic Solutions
Recruiting - verified February 2012 - Conditions: Osteoarthritis; Degenerative Joint Disease
Intervention: Behavioral: Care Navigator
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified February 2012 - Condition: Knee Osteoarthritis
Intervention: Other: Strength Training
Sponsors: Frederiksberg University Hospital; Frederiksberg University Hospital; East Carolina University
Recruiting - verified March 2012 - Condition: Chronic Ankle Instability
Interventions: Other: Ankle Joint Mobilization; Other: Foot Massage; Other: Calf Stretching
Sponsors: University of Kentucky; University of Kentucky; University of North Carolina, Charlotte; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2012 - Condition: Osteoarthritis
Intervention: Procedure: Massage Therapy
Sponsors: Duke University; Duke University; National Center for Complementary and Alternative Medicine (NCCAM)
Not yet recruiting - verified May 2012 - Condition: Osteoarthritis of the Shoulder
Interventions: Device: PyroTITAN, Ascension Orthopedics, Inc.; Device: TITAN, Ascension Orthopedics, Inc.
Sponsors: Danderyd Hospital; Danderyd Hospital; Ascension Orthopedics, Inc.; Swedish Shoulder and Elbow Arthroplasty Register; Karolinska Institutet
Recruiting - verified April 2012 - Condition: Unilateral Knee Osteoarthritis
Intervention: Other: Exercise in eccentric or concentric mode
Sponsors: University Hospital, Clermont-Ferrand; University Hospital, Clermont-Ferrand
Not yet recruiting - verified April 2012 - Condition: Knee Osteoarthritis
Interventions: Other: Usual spa protocol; Other: Active spa protocol
Sponsors: Central Hospital, Nancy, France; Central Hospital, Nancy, France
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Behavioral: Peer Support Program
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Amgen
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: PF-05280586; Biological: MabThera; Biological: Rituxan
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: UCB, Inc.; UCB, Inc.; ReSearch Pharmaceutical Services, Inc.
Recruiting - verified May 2012 - Condition: Knee Osteoarthritis
Interventions: Procedure: Physical Therapy for knee OA; Behavioral: Cognitive Behavioral Therapy for Pain CBT-P; Other: Enhanced Treatment as Usual
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified February 2012 - Condition: Osteoarthritis of the Knee
Interventions: Other: Neuromuscular training (NEMEX-TJR); Behavioral: Information; Drug: Paracetamol; Drug: Burana; Drug: Pantoprazole; Behavioral: Dietary counseling; Behavioral: Patient education; Other: Insoles
Sponsors: Northern Orthopaedic Division, Denmark; Northern Orthopaedic Division, Denmark
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Pain
Interventions: Drug: PF-05089771; Drug: PF-05089771; Drug: PF-05089771; Drug: PF-05089771; Drug: PF-05089771
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention:
Sponsors: Merck; Merck
Not yet recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Certolizumab Pegol + Methotrexate (MTX); Biological: Placebo + Methotrexate (MTX)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Certolizumab Pegol + Methotrexate (MTX); Biological: Placebo + Methotrexate (MTX)
Sponsors: UCB, Inc.; UCB, Inc.
Not yet recruiting - verified January 2012 - Condition: Osteoarthritis
Interventions: Biological: botulinum toxin Type A; Drug: Normal Saline (Placebo)
Sponsors: Allergan; Allergan
Recruiting - verified January 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified April 2012 - Condition: Osteoarthritis, Knee
Interventions: Drug: SI000413; Drug: microcrystalline cellulose
Sponsors: Dong-A Pharmaceutical Co., Ltd.; Dong-A Pharmaceutical Co., Ltd.
Recruiting - verified February 2012 - Condition: Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.
Intervention:
Sponsors: Imperial College London; Imperial College London
Recruiting - verified March 2012 - Conditions: Hyperuricemia; Gout
Interventions: Dietary Supplement: Blueberry Powder; Dietary Supplement: Placebo Powder
Sponsors: University of Mississippi Medical Center; University of Mississippi Medical Center
Recruiting - verified February 2012 - Condition: Scleritis
Intervention: Drug: Sirolimus
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified December 2011 - Condition: End-stage Ankle Osteoarthritis
Interventions: Procedure: Total Ankle Replacement; Procedure: Ankle Arthrodesis
Sponsors: Royal National Orthopaedic Hospital NHS Trust; Razi Zaidi; University College, London; Medical Research Council
Not yet recruiting - verified January 2012 - Conditions: Hyperuricemia; Gout
Intervention: Drug: levotofisopam
Sponsors: Pharmos; Pharmos
Recruiting - verified January 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Conditions: Osteoarthritis; Knee Osteoarthritis
Interventions: Behavioral: Educational Course; Behavioral: Phone Calls; Behavioral: Printed Material
Sponsors: University of Sao Paulo General Hospital; University of Sao Paulo General Hospital
Recruiting - verified April 2012 - Conditions: Osteoarthritis of the Knee; Coagulopathy
Intervention: Drug: PENNSAID (diclofenac sodium solution topical)
Sponsors: Arthritis Treatment Center, Maryland; Nathan Wei, MD, FACP, FACR:; Covidien; Arthritis Treatment Center, Maryland
Recruiting - verified February 2012 - Conditions: Rheumatoid Arthritis; Varicella Zoster
Intervention: Drug: Zostavax (varicella zoster virus) vaccine
Sponsors: Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Tacrolimus
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc; Astellas Pharma Korea, Inc.
Recruiting - verified January 2012 - Condition: Arthritis of Knee
Intervention:
Sponsors: Athens Orthopedic Clinic, P.A.; Athens Orthopedic Clinic, P.A.; Stryker Orthopaedics
Recruiting - verified January 2012 - Conditions: Knee Joint Arthritis; Knee Joint Arthroplasty
Interventions: Procedure: Spinal anesthesia with periarticular infiltration; Procedure: Femoral and sciatic nerve blocks; Procedure: Periarticular infusions
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified January 2012 - Condition: Tophaceous Gout
Interventions: Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified March 2012 - Condition: Inflammatory Rheumatism
Intervention: Behavioral: Telenursing
Sponsors: University of Applied Sciences of Western Switzerland; University of Applied Sciences of Western Switzerland; Swiss National Science Foundation; Réseau d'Etudes aux Confins de la Santé et du Social (RECSS)(HES-SO); University of Lausanne Hospitals; Consultation Multisite Romande de Rhumatologie Pédiatrique; Ligue Genevoise contre le Rhumatisme
Recruiting - verified January 2012 - Condition: Gout
Interventions: Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Condition: Gout
Interventions: Drug: lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Condition: Osteoarthritis of the Knee
Interventions: Drug: Placebo; Drug: Hyruan Plus; Drug: LBSA0103
Sponsors: LG Life Sciences; LG Life Sciences
Recruiting - verified January 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified April 2012 - Conditions: Psoriasis; Arthritis, Psoriatic
Interventions: Drug: CP-690,550; Drug: CP-690, 550
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Certolizumab pegol + Methotrexate (CZP + MTX); Biological: Adalimumab + Methotrexate (ADA + MTX)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Arthritis; Behcet
Intervention: Drug: Adalimumab (Humira)
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus; Abbott
Not yet recruiting - verified December 2011 - Condition: HIV
Intervention: Behavioral: Care management
Sponsors: University of Washington; University of Washington; National Institutes of Health (NIH); National Institute of Mental Health (NIMH); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not yet recruiting - verified January 2012 - Condition: Osteoarthritis
Interventions: Biological: mesenchymal stem cell; Biological: Placebo
Sponsors: Royan Institute; Royan Institute
Recruiting - verified March 2010 - Conditions: Premature Endothelial Dysfunction; Rheumatoid Arthritis; Healthy
Intervention:
Sponsors: Orrin M Troum, M.D. and Medical Associates; Orrin M Troum, M.D. and Medical Associates; Bristol-Myers Squibb
Recruiting - verified December 2011 - Conditions: Chronic Low Back Pain; Degenerative Disc Disease; Depression; Anxiety
Interventions: Drug: Oxycodone; Drug: Morphine
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Arthritis Foundation; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2012 - Conditions: Osteoarthritis, Hip; Arthritis, Rheumatoid; Femur Head Necrosis
Interventions: Procedure: Manual Intervention; Procedure: Navigated Intervention
Sponsors: Aesculap AG; Aesculap AG
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Non-biological DMARD's; Biological: Cimzia, Orencia, RoActemra
Sponsors: Karolinska Institutet; Karolinska Institutet
Not yet recruiting - verified April 2012 - Condition: Hip Osteoarthritis
Intervention: Biological: cell injection
Sponsors: Royan Institute; Royan Institute
Recruiting - verified January 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Pope Research Corporation; Pope Research Corporation
Not yet recruiting - verified December 2011 - Condition: Noninflammatory Degenerative Joint Disease
Intervention: Device: Total Knee Replacement
Sponsors: DePuy Orthopaedics; DePuy Orthopaedics
Recruiting - verified March 2012 - Condition: Hip Osteoarthritis
Intervention: Procedure: Hip arthroplasty
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified December 2011 - Conditions: Osteoarthritis; Post-traumatic Arthritis; Gout; Pseudo-gout
Intervention: Device: SIGMA HP PARTIAL KNEE
Sponsors: DePuy International; DePuy International
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: Adalimumab
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550 or Placebo; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Other: vascular occlusion with exercise trainig; Other: high intensity resistance training; Other: control
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified November 2011 - Condition: Gout
Interventions: Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Optimus Clinical Research; Optimus Clinical Research; Arthritis Australia, Abbott Australia
Recruiting - verified November 2011 - Condition: Hip Osteoarthritis
Interventions: Procedure: Total hip replacement; Procedure: Total hip replacement; Procedure: Total hip replacement
Sponsors: Norwegian University of Science and Technology; Norwegian University of Science and Technology; St. Olavs Hospital
Recruiting - verified January 2012 - Condition: Osteoarthritis, Knee
Interventions: Other: knee OA project; Other: conventional PT
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified May 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis; Ununited Humeral Head Fracture; Irreducible 3-and 4-part Proximal Humeral Fractures; Avascular Necrosis; Gross Rotator Cuff Deficiency; Failed Total Shoulder Arthroplasty (Both Glenoid and Humeral Components Require Revision
Intervention: Device: Trabecular Metal Reverse Shoulder System
Sponsors: Zimmer, Inc.; Zimmer, Inc.
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis; Ununited Humeral Head Fracture; Irreducible 3- and 4-part Proximal Humeral Fractures; Avascular Necrosis
Intervention: Device: Trabecular Metal Humeral Stem
Sponsors: Zimmer, Inc.; Zimmer, Inc.
Recruiting - verified April 2012 - Conditions: Hip Osteoarthritis; Knee Osteoarthritis
Intervention: Other: Shared Decision Making Intervention
Sponsors: University of California, San Francisco; University of California, San Francisco; Stanford University; Robert Wood Johnson Foundation
Recruiting - verified February 2012 - Condition: Knee Osteoarthritis
Interventions: Behavioral: High Intensity Strength Training; Behavioral: Low Intensity Strength Training; Behavioral: Attention Control
Sponsors: Wake Forest University; Wake Forest University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not yet recruiting - verified December 2011 - Condition: Osteoarthritis of the Knee
Interventions: Drug: FX006; Drug: Commercially available triamcinolone acetonide
Sponsors: Flexion Therapeutics, Inc.; Flexion Therapeutics, Inc.
Not yet recruiting - verified May 2012 - Condition: Osteoarthritis of the Knee
Interventions: Drug: FX006; Drug: commercially available triamcinolone acetonide
Sponsors: Flexion Therapeutics, Inc.; Flexion Therapeutics, Inc.
Not yet recruiting - verified May 2012 - Condition: Osteoarthritis of the Knee
Interventions: Procedure: tourniquet; Procedure: no tourniquet
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital
Not yet recruiting - verified December 2011 - Condition: Knee Osteoarthritis
Interventions: Device: double leg press with partial blood flow restriction; Other: double leg press without partial blood flow restriction
Sponsors: University of Iowa; University of Iowa
Recruiting - verified December 2011 - Condition: Primary Sjogren´s Syndrome
Intervention: Other: Aerobic exercise
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified January 2012 - Conditions: Ankylosing Spondylitis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Conditions: Adhesive Capsulitis; Frozen Shoulder
Interventions: Biological: collagenase clostridium histolyticum; Other: Shoulder exercises
Sponsors: Auxilium Pharmaceuticals; Auxilium Pharmaceuticals
Recruiting - verified December 2011 - Condition: Osteoarthritis
Intervention:
Sponsors: University of Nottingham; University of Nottingham
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Osteoarthritis
Interventions: Other: Exercise training; Other: Resistance training with vascular occlusion
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified November 2011 - Conditions: Knee Osteoarthritis; Degenerative Joint Disease; Chronic Pain
Interventions: Drug: Milnacipran; Drug: Placebo
Sponsors: Rehabilitation Institute of Chicago; Dr. Norman Harden; Forest Laboratories
Recruiting - verified January 2012 - Condition: Arthritis, Psoriatic
Interventions: Biological: Placebo matching BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified January 2012 - Condition: Gout
Interventions: Other: Nurse intervention; Other: Standard care
Sponsors: University of Nottingham; University of Nottingham; Arthritis Research UK
Not yet recruiting - verified November 2011 - Condition: Osteoarthritis, Knee
Interventions: Procedure: Bone Marrow Autologous Stem Cells Infusion; Drug: Acetaminophen
Sponsors: Hospital Universitario Dr. Jose E. Gonzalez; Hospital Universitario Dr. Jose E. Gonzalez
Recruiting - verified January 2012 - Conditions: Lupus Erythematosus, Systemic; Arthritis, Rheumatoid
Intervention:
Sponsors: Federal University of São Paulo; Federal University of São Paulo
Recruiting - verified November 2011 - Condition: Arthritis, Rheumatoid
Interventions: Drug: LY3009104; Drug: Placebo; Drug: LY3009104; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified February 2012 - Condition: Knee Osteoarthritis
Interventions: Other: Orthovisc; Device: DonJoy HA lite knee brace; Device: Orthovisc injections and DonJoy HA lite knee brace
Sponsors: OAD Orthopaedics; OAD Orthopaedics
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab; Drug: tocilizumab
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention:
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Not yet recruiting - verified November 2011 - Condition: Osteoarthritis, Knee
Interventions: Device: Ivivi Torino II; Device: Ivivi Torino II
Sponsors: Amp Orthopedics, Inc.; Amp Orthopedics, Inc.
Recruiting - verified November 2011 - Conditions: Temporomandibular Joint; Conservative Treatment Therapy
Intervention: Drug: PET/CT with 18-FDG
Sponsors: University of Pennsylvania; University of Pennsylvania
Recruiting - verified December 2011 - Conditions: Age-related Bone Loss; Age Related Muscle Loss; Falls; Fractures
Interventions: Dietary Supplement: potassium bicarbonate; Dietary Supplement: potassium bicarbonate; Other: placebo
Sponsors: Tufts University; Tufts University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2012 - Conditions: Arthritis; Rheumatoid
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Conditions: Prehypertension; Gout; Pulse Wave Velocity; Hypertension; 24 Hour Blood Pressure
Intervention: Drug: Febuxostat
Sponsors: University of California, San Diego; University of California, San Diego; Takeda Global Research & Development Center, Inc.
Recruiting - verified November 2011 - Condition: Sjogrens Syndrome
Intervention:
Sponsors: Göteborg University; Göteborg University
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo; Biological: Olokizumab 60 mg; Biological: Olokizumab 120 mg; Biological: Olokizumab 240 mg
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Osteoarthritis, Knee
Intervention:
Sponsors: Orthosensor, Inc.; Orthosensor, Inc.
Recruiting - verified January 2012 - Condition: Knee Osteoarthritis
Interventions: Device: Chondroitin sulfate and sodium hyaluronate; Drug: Hyaluronan
Sponsors: Pierre Fabre Medicament; Pierre Fabre Medicament
Not yet recruiting - verified May 2012 - Condition: Chronic Gout
Intervention: Biological: pegloticase
Sponsors: Savient Pharmaceuticals; Savient Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Systemic Sclerosis; Ulcers
Interventions: Drug: macitentan 3mg; Drug: macitentan 10mg; Drug: placebo
Sponsors: Actelion; Actelion
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis; Other Arthritic Conditions (e.g., Psoriatic Arthritis)
Intervention: Behavioral: painACTION: Arthritis
Sponsors: Inflexxion, Inc.; Inflexxion, Inc.
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis, Arthritis, Juvenile Rheumatoid
Intervention: Drug: Tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: BT061; Biological: Placebo
Sponsors: Biotest; Biotest
Recruiting - verified November 2011 - Condition: Degenerative Arthritis
Intervention:
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified November 2011 - Condition: Fibromyalgia Syndrome
Interventions: Biological: Inactivated split virion Influenza vaccine; Biological: WHO recommended 2011 Influenza vacccine
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified October 2011 - Conditions: Osteochondritis Dissecans; Osteoarthritis; Cartilage Injury; Osteonecrosis
Intervention: Procedure: Treatment of cartilage defects in the knee
Sponsors: University Hospital of North Norway; University Hospital of North Norway; University of Tromso
Recruiting - verified May 2012 - Condition: Osteoarthritis
Interventions: Drug: Hyaluronic Acid; Biological: Autologous bone marrow-derived mesenchymal stem cells
Sponsors: National University of Malaysia; National University of Malaysia; Cytopeutics Pte. Ltd.
Recruiting - verified October 2011 - Condition: Osteoarthritis of Knee
Interventions: Biological: Ex- vivo cultured adult allogeneic MSCs; Biological: Plasmalyte-A
Sponsors: Stempeutics Research Pvt Ltd; Stempeutics Research Pvt Ltd
Recruiting - verified February 2012 - Condition: Adhesive Capsulitis
Interventions: Procedure: Isotonic saline injection into the glenohumeral joint; Procedure: Allogenic PRP injection into the glenohumeral joint
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Recruiting - verified December 2011 - Condition: Painful Diabetic Peripheral Neuropathy
Interventions: Drug: pregabalin; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Knee Osteoarthritis
Interventions: Device: Ivivi SofPulse; Device: Ivivi SofPulse
Sponsors: Amp Orthopedics, Inc.; Amp Orthopedics, Inc.
Recruiting - verified December 2011 - Condition: Vaccine Response Impaired
Interventions: Biological: hepatitis A vaccine; Biological: hepatitis A vaccine
Sponsors: Sormland County Council, Sweden; Sormland County Council, Sweden
Recruiting - verified October 2011 - Condition: Spondylitis, Ankylosing
Interventions: Drug: Golimumab; Drug: Placebo
Sponsors: Schering-Plough; Schering-Plough; Johnson & Johnson
Recruiting - verified April 2012 - Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout FlaresCondition: Gout
Interventions: Drug: Rilonacept; Drug: Placebo; Drug: Allopurinol
Sponsors: Regeneron Pharmaceuticals; Regeneron Pharmaceuticals
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: Certolizumab pegol
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Conditions: Osteoarthritis Knee; Postoperative Pain
Interventions: Device: echogenic needle and catheter; Device: Neurostimulation to position needle and catheter
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; The Physicians' Services Incorporated Foundation
Not yet recruiting - verified January 2012 - Condition: Intercritical Gout
Interventions: Drug: Colchicine; Drug: Placebo; Drug: Allopurinol
Sponsors: Regeneron Pharmaceuticals; Regeneron Pharmaceuticals
Recruiting - verified April 2012 - Condition: Ankle Osteoarthritis
Intervention: Other: Total Ankle Replacement Surgery
Sponsors: Duke University; Duke University
Recruiting - verified January 2012 - Condition: Duchenne Muscular Dystrophy
Intervention:
Sponsors: University of Florida; University of Florida; University of Pennsylvania; Oregon Health and Science University; Children's Hospital of Philadelphia; Shriners Hospitals for Children; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: placebo of CDP870; Drug: CDP870
Sponsors: Otsuka Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; UCB Japan Co., LTD.
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Low Back Pain
Intervention: Drug: COV795
Sponsors: Mallinckrodt; Mallinckrodt
Recruiting - verified March 2012 - Conditions: Pain; Osteoarthritis
Interventions: Procedure: Canal Block and Capsular Injection; Procedure: Femoral Nerve Block with Tibial Nerve Block
Sponsors: Saint Francis Care; Saint Francis Care
Recruiting - verified October 2011 - Condition: Adhesive Capsulitis
Intervention:
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Recruiting - verified October 2011 - Condition: Osteoarthritis
Interventions: Behavioral: GUIDED IMAGERY; Behavioral: PLACEBO
Sponsors: Kent State University; Kent State University; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: tDMARDs; Drug: biodmards
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Hip Osteoarthritis
Interventions: Device: AposTherapy Biomechanical System; Other: Control
Sponsors: HaEmek Medical Center, Israel; HaEmek Medical Center, Israel
Not yet recruiting - verified October 2011 - Conditions: Autoimmune/Connective Tissue Diseases; Immune System Diseases; Behcet's Disease
Interventions: Drug: Anakinra; Other: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified August 2011 - Condition: Influenza
Interventions: Biological: 2011-2012 Sanofi Pasteur Fluzone®; Biological: 2011-2012 Sanofi Pasteur Fluzone® High Dose
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Conditions: Osteoarthrosis; Total Hip Arthroplasty
Intervention: Procedure: x-pander
Sponsors: Northern Orthopaedic Division, Denmark; Northern Orthopaedic Division, Denmark; Medichanical Engineering
Recruiting - verified November 2011 - Condition: Knee Osteoarthritis
Intervention: Other: Subject outcomes following viscosupplementation of the knee
Sponsors: University of Florida; University of Florida
Recruiting - verified April 2012 - Condition: Osteoarthritis of Knee Joint
Interventions: Biological: Ex- vivo cultured adult allogeneic MSCs; Biological: Plasmalyte-A
Sponsors: Stempeutics Research Pvt Ltd; Stempeutics Research Pvt Ltd; Stempeutics Research Malaysia SDN BHD
Recruiting - verified December 2011 - Conditions: Osteoarthritis; Avascular Necrosis; Rheumatoid Arthritis; Developmental Dysplasia of the Hip
Intervention:
Sponsors: Wirral University Teaching Hospital NHS Trust; Hussain Kazi
Not yet recruiting - verified September 2011 - Condition: Juvenile Idiopathic Arthritis
Intervention:
Sponsors: Blood Transfusion Centre of Slovenia; Blood Transfusion Centre of Slovenia; University Medical Centre Ljubljana
Not yet recruiting - verified September 2011 - Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: comparison of types of sleep disordered breathing
Sponsors: University of Washington; University of Washington
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Revamilast; Drug: Revamilast; Drug: Revamilast; Drug: Placebo Comparator
Sponsors: Glenmark Pharmaceuticals Ltd. India; Glenmark Pharmaceuticals Ltd. India; Glenmark Pharmaceuticals SA
Recruiting - verified December 2011 - Conditions: Cat-scratch Disease; Bartonella Infections
Interventions: Drug: prednison and azithromycin; Drug: prednison, azithromycin; Drug: prednison, Azenil
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified November 2011 - Condition: Acute Gouty Arthritis
Intervention: Drug: Canakinumab 150mg in prefilled syringe
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Ankylosing Spondylitis
Intervention: Behavioral: Exercise
Sponsors: Diakonhjemmet Hospital; Diakonhjemmet Hospital; University of Oslo
Recruiting - verified October 2011 - Condition: Osteoarthritis
Interventions: Behavioral: Patient Behavioral Intervention for OA; Behavioral: Provider Intervention for OA; Behavioral: Combined Patient and Provider Interventions for OA
Sponsors: Duke University; Duke University; National Institutes of Health (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified September 2011 - Condition: Peripheral Spondylarthritis
Interventions: Drug: Placebo; Drug: Golimumab
Sponsors: University Hospital, Ghent; University Hospital, Ghent; Janssen Biologics B.V.
Recruiting - verified March 2012 - Conditions: Osteoarthritis, Knee; Obesity
Intervention: Behavioral: 8 weeks weight loss program, Cambridge.
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified November 2011 - Condition: Osteoarthritis of the Knee
Interventions: Drug: Meloxicam; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Arthritis; Spondylitis, Ankylosing
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2012 - Conditions: Fasciitis, Plantar; Achillodynia; Periarthritis Calcarea; Epikondylopathia Humeri /Radii
Intervention:
Sponsors: University of Zurich; University of Zurich
Recruiting - verified August 2011 - Condition: Juvenile Idiopahtic Arthritis
Intervention: Drug: etanercept
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Psoriatic Arthritis
Interventions: Drug: AMG 827; Drug: Placebo; Drug: AMG 827
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Other: SC anti-TNF
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Interstitial Lung Disease; Connective Tissue Disease
Intervention: Drug: N-Acetylcysteine
Sponsors: University of Michigan; University of Michigan
Recruiting - verified December 2011 - Condition: Knee Osteoarthritis
Interventions: Procedure: Orthopaedic manual physical therapy; Procedure: Corticosteroid Injection
Sponsors: Madigan Army Medical Center; Madigan Army Medical Center; Brooke Army Medical Center
Recruiting - verified April 2012 - Conditions: Cytokine Environment; Kinetics of Bone Cells Differentiation and Activity in Untreated RA and AS Patients.
Intervention:
Sponsors: Instituto de Medicina Molecular; Instituto de Medicina Molecular; Merck
Not yet recruiting - verified December 2011 - Condition: Osteoarthritis
Intervention: Dietary Supplement: Rosehip powder
Sponsors: Frederiksberg University Hospital; Frederiksberg University Hospital; Axellus A/S, Ishøj, Denmark; Oak Foundation, Geneva
Recruiting - verified September 2011 - Condition: Chronic Gouty Arthritis
Intervention: Biological: canakinumab
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Pathogenesis; Sjogren's Syndrome; Salivary Gland
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified January 2012 - Condition: Relapsing Remitting Multiple Sclerosis
Intervention:
Sponsors: University of Southern California; University of Southern California; Teva Pharmaceuticals USA
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo to Secukinumab (AIN457); Biological: Secukinumab
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Osteoarthritis of the Hip
Interventions: Device: Metaphyseal Hip Prosthesis; Device: Stanmore hip prosthesis
Sponsors: Biomet, Inc.; Biomet, Inc.
Not yet recruiting - verified February 2012 - Condition: Osteoarthritis
Intervention: Other: Total knee replacement rehabilitation
Sponsors: University of Colorado, Denver; University of Colorado, Denver; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2012 - Condition: Acute Rheumatoid Arthritis
Intervention: Drug: s.c. injections of bovine intestinal Alkaline Phosphatase
Sponsors: Alloksys Life Sciences B.V.; Alloksys Life Sciences B.V.; Aix Scientifics
Recruiting - verified August 2011 - Condition: Knee Osteoarthritis
Interventions: Drug: Chondroitin sulfate/ Glucosamine hydrochloride; Drug: Celecoxib
Sponsors: Bioiberica; Bioiberica
Recruiting - verified October 2011 - Conditions: Arthritis; Rheumatoid; High Dose
Intervention: Drug: Methotrexate (MTX)
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Shoulder Impingement Syndrome; Arthritis
Intervention: Drug: Dexamethasone
Sponsors: University of Aarhus; University of Aarhus; Horsens Hospital; Central Denmark Region; The Family Hede Nielsens Fund; The Danish Rheumatism Association
Recruiting - verified January 2012 - Condition: Arthritis, Juvenile Rheumatoid
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Hip Arthrosis
Interventions: Device: THA with ABG II / Trident; Device: THA with CLS / Trilogy
Sponsors: Vejle Hospital; Vejle Hospital
Recruiting - verified November 2011 - Condition: Osteoathritis and Sleep
Intervention: Behavioral: Balance and muscle strength
Sponsors: Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Federal University of São Paulo
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: masitinib; Drug: masitinib; Drug: methotrexate
Sponsors: AB Science; AB Science
Recruiting - verified May 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: MRC375; Drug: Matching Placebo; Drug: MRC375 150mg
Sponsors: Molecular Research Center, Inc.; Molecular Research Center, Inc.; Camargo Pharmaceutical Services; Rho; Clin Data Services; Harrison Clinical Research; BARC Global Central Laboratory; Bilcare Global Clinical Supplies
Recruiting - verified January 2012 - Condition: Moderate to Severe Pain Associated With Osteoarthritis of the Hip or Knee
Interventions: Drug: Acetaminophen; Drug: Maxigesic USA; Drug: Ibuprofen; Drug: Placebo
Sponsors: AFT Pharmaceuticals, Ltd.; AFT Pharmaceuticals, Ltd.
Not yet recruiting - verified August 2011 - Condition: Osteoarthritis of Subtalar Joint
Intervention: Biological: Platelet Rich Plasma
Sponsors: Meir Medical Center; Meir Medical Center
Not yet recruiting - verified August 2011 - Condition: Ankylosing Spondylitis
Intervention: Biological: Human umbilical cord-derived MSCs
Sponsors: Shandong University; Shandong University
Recruiting - verified April 2011 - Condition: Rheumatoid Arthritis
Intervention: Other: No intervention
Sponsors: Rigshospitalet, Denmark; Rigshospitalet, Denmark
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo; Drug: BMS-817399; Drug: BMS-817399
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified March 2012 - Condition: Osteoarthritis
Interventions: Device: Active Device (Torino II); Device: Sham Device (Torino II)
Sponsors: Center for Joint Surgery and Sports Medicine, Maryland; Center for Joint Surgery and Sports Medicine, Maryland
Recruiting - verified August 2011 - Condition: Lumbar Spine Degeneration
Interventions: Device: INFUSE Bone Graft; Other: Iliac Crest Bone Graft
Sponsors: Medtronic Spinal and Biologics; Medtronic Spinal and Biologics
Recruiting - verified March 2012 - Condition: Wiskott-Aldrich Syndrome
Intervention: Biological: Retrovirus-mediated gene transfer
Sponsors: Children's Hospital Boston; Children's Hospital Boston
Recruiting - verified August 2011 - Condition: Osteoarthritis
Interventions: Device: Sigma CR150; Device: Sigma CR
Sponsors: DePuy International; DePuy International
Recruiting - verified February 2012 - Condition: Psoriasis
Intervention:
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: Teriparatide
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Eli Lilly and Company
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: ISIS CRP Rx or Placebo
Sponsors: Isis Pharmaceuticals; Isis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention:
Sponsors: Istituto Giannina Gaslini; Istituto Giannina Gaslini; Members of the PRINTO network (PRINTO at www.printo.it)
Not yet recruiting - verified May 2011 - Condition: Osteoarthritis of the Knee
Interventions: Other: Neuromuscular training (NEMEX-TJR); Drug: Paracetamol; Drug: Burana; Drug: Pantoprazol; Behavioral: Dietary counseling; Behavioral: Patient education; Procedure: TKR; Other: Insoles
Sponsors: Northern Orthopaedic Division, Denmark; Northern Orthopaedic Division, Denmark; The Danish Rheumatism Association; Obel Family Foundation; Spar Nord Foundation; The Bevica Foundation; Aalborg University; The Association of Danish Physiotherapists Research Fund; Formthotics; Medical Specialist Heinrich Kopp's Grant
Recruiting - verified February 2012 - Conditions: Rheumatoid Arthritis; Lupus Erythematosus, Systemic; Sjogren's Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified May 2012 - Conditions: Knee Replacement Surgery; Osteoarthritis
Interventions: Other: Standard of Care; Drug: FLOSEAL Hemostatic Matrix
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Recruiting - verified February 2012 - Conditions: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Osteoarthritis; Post-traumatic Arthritis
Intervention: Device: Ascension MCP Finger Implant
Sponsors: Ascension Orthopedics, Inc.; Ascension Orthopedics, Inc.
Recruiting - verified July 2011 - Condition: Arthritis
Intervention: Drug: sodium citrate and citric acid
Sponsors: Texas Tech University Health Sciences Center; Texas Tech University Health Sciences Center
Recruiting - verified August 2011 - Conditions: Knee Arthroplasty; Knee Arthritis Osteoarthritis; Osteoarthritis; Osteoarthritis, Knee; Musculoskeletal Diseases
Interventions: Device: AposTherapy Biomechanical System; Other: Physical Therapy Program
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Prednisolone
Sponsors: Rheumazentrum Ruhrgebiet; Rheumazentrum Ruhrgebiet
Not yet recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Reumatocept (etanercept); Drug: Enbrel (etanercept)
Sponsors: EMS; EMS
Not yet recruiting - verified July 2011 - Conditions: Low Back Pain; Osteoarthritis
Intervention: Behavioral: mindfulness group meetings with psychologist
Sponsors: Meir Medical Center; Meir Medical Center
Not yet recruiting - verified August 2011 - Condition: Polymyalgia Rheumatica (PMR)
Intervention: Drug: Tocilizumab
Sponsors: Hospital for Special Surgery, New York; Hospital for Special Surgery, New York; Genentech
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified July 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tetrahydrobiopterin (BH4); Drug: non-acetylated salicylate; Dietary Supplement: High Fat Meal; Drug: L-NMMA; Dietary Supplement: Antioxidant Cocktail
Sponsors: Georgia Health Sciences University; Georgia Health Sciences University; American Heart Association
Recruiting - verified July 2011 - Condition: Psoriatic Arthritis
Interventions: Biological: Secukinumab (75 mg); Biological: Secukinumab (150 mg); Biological: Placebo Comparator
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: MK-8808 500 mg/m^2; Biological: Rituximab 500 mg/m^2; Drug: Methotrexate; Biological: MabThera (rituximab) 500 mg/m^2; Biological: Rituxan (rituximab) 500 mg/m^2; Biological: MK-8808 1000 mg
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Osteoarthritis, Knee
Intervention: Behavioral: Gait retraining
Sponsors: Stanford University; Stanford University
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Conditions: Dry Eye; Sjogren's Syndrome; Graft vs. Host Disease
Intervention: Drug: Thymosin Beta 4 eye drops vs. vehicle
Sponsors: Michigan Cornea Consultants, PC; Michigan Cornea Consultants, PC; Kresge Eye Institute
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab
Sponsors: The Rheumatological Center of Helsinki; The Rheumatological Center of Helsinki; Abbott
Recruiting - verified July 2011 - Condition: Osteoarthritis, Knee
Interventions: Procedure: Conventional Instrumentation; Procedure: Signature Custom Guides
Sponsors: Biomet, Inc.; Biomet, Inc.
Not yet recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: University Hospital Muenster; University Hospital Muenster
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Condition: Ankylosing Spondylitis
Intervention:
Sponsors: Abbott; Abbott; JSS Medical Research Inc.; CATO Research Canada
Recruiting - verified April 2012 - Conditions: Primary Arthritis; Secondary Arthritis
Intervention: Device: Silent™ Hip
Sponsors: DePuy International; DePuy International
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan]; Drug: methotrexate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Psoriasis
Intervention:
Sponsors: Abbott; Abbott; CATO Research Canada; JSS Medical Research Inc.
Recruiting - verified May 2012 - Condition: Gout
Intervention: Drug: Allopurinol
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Condition: Arthritis
Intervention: Behavioral: Vocational Rehabilitation Intervention
Sponsors: Boston University; Boston University; U.S. Department of Education
Recruiting - verified July 2011 - Condition: Hip Osteoarthritis
Interventions: Procedure: Strength training; Procedure: Nordic Walking; Procedure: Unsupervised home based exercise
Sponsors: Bispebjerg Hospital; Bispebjerg Hospital
Recruiting - verified June 2011 - Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell TransplantationCondition: Graft Versus Host Disease
Intervention: Drug: Oral Cannabidiol
Sponsors: Rabin Medical Center; Rabin Medical Center
Not yet recruiting - verified April 2011 - Conditions: Moderate to Severe Plaque Psoriasis; Antibodies; Monoclonals
Intervention:
Sponsors: Abbott; Abbott; Mag. Andreas Raffeiner GMBH
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Secukinumab (75 mg); Drug: Secukinumab (150 mg); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Osteoarthritis of the Basal Joint of the Thumb
Intervention:
Sponsors: Columbia University; Columbia University; Arthritis Foundation; American Society for Surgery of the Hand
Recruiting - verified January 2012 - Conditions: Chronic Pain; Osteoarthritis
Intervention: Device: Transcranial Direct Current Stimulation
Sponsors: Spaulding Rehabilitation Hospital; Spaulding Rehabilitation Hospital; Highland Instruments
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Open Label Drug Certolizumab Pegol (CZP); Procedure: Arthroscopic synovial tissue biopsy
Sponsors: Arthritis Treatment Center, Maryland; Nathan Wei, MD, FACP, FACR:; University of California, San Diego
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: prednisone; Other: prednisone; Other: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: BMS-945429 Placebo; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Drug: Methotrexate; Drug: Methotrexate; Drug: Methotrexate Placebo; Drug: Methotrexate; Drug: Adalimumab Placebo; Drug: Adalimumab
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified January 2012 - Conditions: Osteoarthritis of the Knee; Traumatic Arthritis of the Knee
Intervention: Procedure: Total knee arthroplasty
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Not yet recruiting - verified June 2011 - Condition: Knee Osteoarthritis
Interventions: Biological: platelet-rich plasma; Drug: Corticosteroid
Sponsors: Hospital Universitari Vall d'Hebron Research Institute; Hospital Universitari Vall d'Hebron Research Institute
Recruiting - verified March 2012 - Conditions: Traumatic Knee Injury; Knee Osteoarthritis
Intervention:
Sponsors: Lund University; Lund University; The Swedish Research Council; Crafoord Foundation
Recruiting - verified March 2012 - Condition: Knee Osteoarthritis
Intervention: Drug: Voltaren
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Endo Pharmaceuticals
Recruiting - verified June 2011 - Conditions: Osteoarthritis; Chronic Pain
Intervention: Drug: duloxetine, diclofenac
Sponsors: University of Michigan; University of Michigan; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Research Resources (NCRR); Merck; Nuvo Research Inc.
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Prednisolone; Drug: dipyridamole; Drug: Prednisone; Drug: prednisolone-dipyridamole; Other: placebo
Sponsors: Zalicus; Zalicus
Recruiting - verified June 2011 - Condition: Osteoarthritis of the Knee
Interventions: Other: Commercially spearmint tea; Other: High Rosmarinic Acid Spearmint Tea
Sponsors: University of Guelph; University of Guelph; Ontario Ministry of Agriculture and Rural Affairs
Recruiting - verified April 2011 - Condition: Osteoarthritis of the Knee
Intervention: Behavioral: TLC
Sponsors: Boston University; Boston University; U.S. Department of Education
Not yet recruiting - verified July 2011 - Conditions: Degenerative Joint Disease; Osteoarthritis; Knee Injury, Trauma; Connective Tissue Disorder; Pain; Loss of Function
Intervention:
Sponsors: Loma Linda University; Loma Linda University
Not yet recruiting - verified June 2011 - Conditions: Rheumatoid Arthritis of Ankle; Osteoarthritis of Ankle; Traumatic Arthritis of Ankle
Intervention:
Sponsors: Orthopaedic Associates of Michigan, PC; Orthopaedic Associates of Michigan, PC
Recruiting - verified June 2011 - Condition: Rheumatoid Arthritis
Intervention: Other: Observational study
Sponsors: Canadian Research & Education in Arthritis; Canadian Research & Education in Arthritis; Abbott
Recruiting - verified November 2011 - Conditions: Arthrodesis; Degenerative Arthritis; Rheumatoid Arthritis; Complications; Arthroplasty, Mechanical
Intervention:
Sponsors: Wright Medical Technology; Wright Medical Technology; Duke University
Recruiting - verified June 2011 - Conditions: Rheumatoid Arthritis; Inflammation
Interventions: Drug: NNC 0141-0000-0100; Drug: placebo; Drug: NNC 0141-0000-0100; Drug: placebo; Drug: NNC 0141-0000-0100; Drug: placebo
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified January 2012 - Conditions: Osteoarthritis; Knee Infection; Prosthetic Joint Infection; Complications; Arthroplasty, Infection or Inflammation; Complications; Arthroplasty
Interventions: Procedure: Static Spacer; Procedure: Articulating Spacer
Sponsors: Rush University Medical Center; Rush University Medical Center; Central DuPage Hospital
Recruiting - verified June 2011 - Conditions: Osteoarthritis; Hip Infection; Prosthetic Joint Infection; Complications; Arthroplasty, Infection or Inflammation; Complications; Arthroplasty
Interventions: Procedure: Implantation of a static, non-articulating cement spacer.; Procedure: Implantation of an articulating spacer.
Sponsors: Rush University Medical Center; Rush University Medical Center; Thomas Jefferson University; Central DuPage Hospital
Recruiting - verified June 2011 - Condition: Healthy Control Subjects
Interventions: Drug: Anakinra; Drug: Placebo
Sponsors: University of North Carolina, Chapel Hill; Michelle Hernandez, MD; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention:
Sponsors: Hammond, Allan, M.D.; Hammond, Allan, M.D.
Recruiting - verified June 2011 - Conditions: Uveitis; Juvenile Arthritis
Interventions: Drug: Anti-tumor necrosis factor alpha monoclonal antibody; Drug: placebo
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Abbott
Recruiting - verified July 2011 - Condition: Gouty Arthritis
Interventions: Biological: Canakinumab, ACZ885; Drug: Triamcinolone acetonide
Sponsors: Novartis; Novartis
Recruiting - verified April 2012 - Conditions: Acute Blood Loss Anemia; Osteoarthritis, Knee
Interventions: Drug: Tranexamic Acid; Drug: Placebo
Sponsors: Henry Ford Health System; Henry Ford Health System
Recruiting - verified April 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: secukinumab; Biological: secukinumab; Biological: placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention:
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Not yet recruiting - verified May 2012 - Condition: Osteoarthritis of the Knee
Interventions: Drug: ARRY-371797, p38 inhibitor; oral; Drug: Oxycodone hydrochloride (HCl) extended release (ER), opioid agonist; oral; Drug: Placebo; oral
Sponsors: Array BioPharma; Array BioPharma
Recruiting - verified March 2012 - Condition: Osteoarthritis
Intervention:
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified June 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: MORAb-022
Sponsors: Eisai Inc.; Eisai Inc.
Recruiting - verified March 2012 - Conditions: Unilateral Primary Osteoarthritis of Knee; Primary Osteoarthritis of Knee Nos
Interventions: Device: Placebo TENS; Device: Intense TENS (EMPI Select TENS)
Sponsors: University of Iowa; University of Iowa
Recruiting - verified May 2011 - Condition: Knee Osteoarthritis
Interventions: Device: MM-II; Device: DurolaneTM
Sponsors: Moebius Medical Ltd.; Moebius Medical Ltd.
Recruiting - verified April 2012 - Condition: Acute Gouty Arthritis
Interventions: Drug: Canakinumab pre-filled syringe; Drug: Canakinumab lyophilized cake; Drug: Triamcinolone Acetonide
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: naproxen; Drug: esomeprazole
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified June 2011 - Conditions: Osteoporosis; Bone Diseases, Metabolic; Hip Fractures
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified January 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis
Intervention: Drug: Enbrel
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Secukinumab (75 mg); Biological: Secukinumab (150 mg); Biological: Placebo; Biological: Abatacept
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention: Procedure: Lumbar Plexus Block
Sponsors: Milton S. Hershey Medical Center; Milton S. Hershey Medical Center
Not yet recruiting - verified April 2012 - Condition: Low Back Pain
Interventions: Drug: Oxycodone/Naloxone Controlled-release; Drug: Placebo
Sponsors: Purdue Pharma LP; Purdue Pharma LP
Recruiting - verified February 2012 - Condition: Osteoarthritis of the Knee
Intervention:
Sponsors: Spokane Joint Replacement Center; Spokane Joint Replacement Center
Recruiting - verified June 2011 - Condition: Obesity
Intervention: Behavioral: Interventions
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Condition: Ankylosing Spondylitis
Interventions: Biological: Secukinumab (75 mg); Biological: Secukinumab (150 mg); Biological: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Autoimmune Diseases; Systemic Inflammatory Process; Knee Pain Chronic; Osteoarthritis; Rheumatoid Arthritis
Interventions: Drug: Fish Oil; Drug: Vitamin D; Other: placebo pill
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Condition: Osteoarthritis
Interventions: Dietary Supplement: ARTRONAT; Dietary Supplement: PLACEBO
Sponsors: Lescuyer Laboratory; Lescuyer Laboratory; RDVC Produit de Santé.; Association Nationale de Prévention Médicale.
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: Tocilizumab+Methotrexate(MTX)
Sponsors: Chugai Pharma Taiwan; Chugai Pharma Taiwan
Recruiting - verified April 2012 - Condition: Revision Surgery of Total Hip Arthroplasty
Interventions: Drug: Denosumab; Other: Placebo
Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; Sheffield Teaching Hospitals NHS Foundation Trust; Amgen; NIHR Musculoskeletal BRU
Not yet recruiting - verified December 2011 - Condition: Early Inflammatory Arthritis
Interventions: Behavioral: One-on-one peer support; Behavioral: Standard of care
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Rheumatology Association; Mount Sinai Hospital, Toronto, Canada; The Arthritis Society, Canada; St. Michael's Hospital, Toronto; University of Toronto
Recruiting - verified December 2011 - Condition: Early Inflammatory Arthritis
Intervention: Behavioral: Peer Mentor Training
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Rheumatology Association; The Arthritis Society, Canada; Mount Sinai Hospital, Toronto, Canada; St. Michael's Hospital, Toronto; University of Toronto
Recruiting - verified December 2011 - Condition: Knee Osteoarthritis
Intervention: Procedure: Total knee arthroplasty performed under tourniquet
Sponsors: Vilnius University; Vilnius University; Karolinska Institutet
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Special Investigation in Patients With Rheumatoid Arthritis (HOPE3 Study Follow up Survey (P12-069))Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Knee Osteoarthritis
Intervention: Drug: Chondroitin sulfate
Sponsors: Bioiberica; Bioiberica
Recruiting - verified August 2011 - Condition: Osteoarthritis, Hip
Intervention:
Sponsors: McMaster University; McMaster University; DePuy Orthopaedics
Not yet recruiting - verified July 2011 - Condition: Ankylosing Spondylitis
Intervention: Other: Exercise
Sponsors: Federal University of São Paulo; Federal University of São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified May 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified October 2011 - Condition: Knee Osteoarthritis
Intervention: Other: Resistance training
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified November 2011 - The Difference Between Rehabilitation With or Without Strength Training After Total Knee ReplacementCondition: Osteoarthritis, Knee
Interventions: Other: Rehabilitation with strength training; Other: Rehabilitation without strength training
Sponsors: Copenhagen University Hospital, Hvidovre; Copenhagen University Hospital, Hvidovre
Recruiting - verified October 2011 - Conditions: Rheumatoid Arthritis; Pregnancy; TNFalfa Inhibitors; Preconceptional Counselling; Disease Activity
Intervention:
Sponsors: Erasmus Medical Center; Erasmus Medical Center; Dutch Association of Rheumatology NVR
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Intervention: Biological: Subcutaneous Abatacept
Sponsors: Orrin M Troum, M.D. and Medical Associates; Orrin M Troum, M.D. and Medical Associates; Bristol-Myers Squibb
Recruiting - verified December 2011 - Condition: Cardiovascular Disease, Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: etanercept
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified March 2012 - Condition: Osteoarthritis, Knee
Interventions: Device: Transcutaneous electric nerve stimulation; Device: sham transcutaneous electrical nerve stimulation
Sponsors: Vrije Universiteit Brussel; Vrije Universiteit Brussel
Not yet recruiting - verified April 2011 - Condition: Ankylosing Spondylitis
Intervention: Drug: Ustekinumab
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany
Recruiting - verified October 2011 - Condition: Osteoarthritis
Interventions: Drug: Milnacipran; Drug: Placebo
Sponsors: Analgesic Solutions; Analgesic Solutions; Forest Laboratories
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: rituximab [MabThera/Rituxan]; Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Conditions: Marfan Syndrome; Turner Syndrome; Ehlers-Danlos Syndrome; Loeys-Dietz Syndrome; FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation; Bicuspid Aortic Valve Without Known Family History; Bicuspid Aortic Valve With Family History; Bicuspid Aortic Valve With Coarctation; Familial Thoracic Aortic Aneurysm and Dissections; Shprintzen-Goldberg Syndrome; Other Aneurysms and Dissections of the Thoracic Aorta Not Due to Trauma, <50yo; Other Congenital Heart Disease
Intervention:
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Condition: Coxarthrosis
Intervention: Device: Primoris
Sponsors: Biomet, Inc.; Biomet, Inc.; Biomet Denmark A/S
Recruiting - verified May 2012 - Conditions: Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing
Intervention: Drug: Simponi®
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: etanercept
Sponsors: Amgen; Amgen
Recruiting - verified March 2012 - Conditions: Diabetic Foot; Osteoarthritis
Interventions: Procedure: Bone scintigraphy; Procedure: Leukoscan; Procedure: PET / CT
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified July 2011 - Condition: Arthritis
Interventions: Procedure: General anesthesia; Procedure: Regional anesthesia
Sponsors: Region Skane; Region Skane
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Ankylosing Spondylitis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Conditions: Sjogren's Syndrome; Xerostomia
Intervention: Drug: Dexamethasone
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified November 2011 - Condition: Anterior Cruciate Ligament Injury
Interventions: Procedure: Anatomic Double-Bundle ACL Reconstruction; Procedure: Anatomic Single-Bundle ACL Reconstruction
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified March 2011 - Conditions: Degenerative Joint Disease; Congenital Deformity; Arthritis; Osteoarthritis; Rheumatoid Arthritis
Interventions: Device: Augment(tm) Injectable Bone Graft; Procedure: Autologous bone graft
Sponsors: BioMimetic Therapeutics; BioMimetic Therapeutics
Recruiting - verified July 2011 - Condition: Osteoarthritis of the Knee
Intervention: Other: Questionnaires
Sponsors: University of Nottingham; University of Nottingham; Arthritis Research Campaign
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: MT203; Drug: Placebo
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Condition: Bone and Joint Infections
Intervention:
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France
Recruiting - verified March 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: TcLand Expression S.A.; TcLand Expression S.A.; Premier Research Group plc; Theradis pharma; Medpharmgene Inc.
Recruiting - verified October 2011 - Conditions: Psoriasis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: CDP6038
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Janssen Korea, Ltd., Korea; Janssen Korea, Ltd., Korea
Not yet recruiting - verified August 2011 - Condition: Osteoarthritis
Interventions: Other: Exercise; Other: manual therapy
Sponsors: Agency for Healthcare Research and Quality (AHRQ); Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified November 2010 - Condition: Rheumatoid Arthritis
Intervention: Drug: therapy with disease-modifying anti rheumatic drugs (DMARD)
Sponsors: University of Zurich; University of Zurich
Recruiting - verified February 2012 - Condition: Interstitial Cystitis
Interventions: Drug: Adalimumab; Other: inactive drug
Sponsors: ICStudy, LLC; ICStudy, LLC; Abbott
Recruiting - verified May 2012 - Conditions: Barrett's Esophagus; Erosive Esophagitis; Gastroesophageal Reflux Disease(GERD)
Intervention:
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institutes of Health (NIH)
Recruiting - verified November 2011 - A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial SpondyloarthritisCondition: Axial Spondyloarthritis
Interventions: Drug: etanercept; Drug: etanercept; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified March 2012 - Conditions: Rheumatoid Arthritis; Osteoporosis; Osteopenia
Interventions: Biological: Ibandronate; Biological: Placebo
Sponsors: Seoul National University Hospital; Yeong-Wook Song
Recruiting - verified January 2012 - Condition: Arthritis
Intervention: Device: Placement of different catheters for continuous nerve block
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: adalimumab; Drug: Placebo; Drug: Placebo; Drug: methotrexate; Drug: folate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Conditions: Lumbar Spondylosis; Lumbar Spondylolisthesis; Adult Degenerative Lumbar Scoliosis
Intervention: Biological: teriparatide
Sponsors: University of California, San Francisco; University of California, San Francisco; Eli Lilly and Company
Recruiting - verified September 2011 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Osteoarthritis
Interventions: Procedure: Hemiarthroplasty; Procedure: Total arthroplasty
Sponsors: AO Clinical Investigation and Documentation; AO Clinical Investigation and Documentation; Synthes GmbH
Not yet recruiting - verified February 2011 - Condition: Osteoarthritis Patient
Intervention: Drug: Ostenil plus
Sponsors: TRB Chemedica; TRB Chemedica
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Conditions: Postmenopausal Osteoporosis; Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: Denosumab
Sponsors: Amgen; Amgen
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: GP2013; Biological: rituximab
Sponsors: Sandoz; Sandoz; Novartis Pharmaceuticals
Recruiting - verified November 2011 - Conditions: Fibromyalgia; Painful Diabetic Peripheral Neuropathy
Interventions: Other: prior authorization; Other: no prior authorization; Other: prior authorization; Other: no prior authorization
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Adalimumab
Sponsors: Keio University; Keio University; Saitama Medical University
Recruiting - verified December 2010 - Condition: Osteoarthrosis in Knee-joint
Intervention: Procedure: Total Knee Arthroplasty
Sponsors: Northern Orthopaedic Division, Denmark; Northern Orthopaedic Division, Denmark
Recruiting - verified August 2011 - Condition: Pancreatic Cancer
Interventions: Drug: Hydroxychloroquine; Drug: Hydroxychloroquine
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute; Brigham and Women's Hospital; Massachusetts General Hospital
Recruiting - verified March 2012 - Condition: Osteoarthritis Pain of the Hip and or Knee
Intervention: Drug: Buprenorphine transdermal patch
Sponsors: Mundipharma AB; Mundipharma AB
Recruiting - verified October 2011 - Condition: Fibromyalgia
Interventions: Drug: pregabalin; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention: Device: ADM Cup
Sponsors: Dalhousie University; Dalhousie University
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Adalimumab and placebo of fostamatinib; Drug: Placebo of fostamatinib, fostamatinib, and placebo injections
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Polyarticular Course Juvenile Idiopathic Arthritis
Intervention: Drug: Givinostat
Sponsors: Italfarmaco; Italfarmaco
Recruiting - verified January 2012 - Condition: Degenerative Meniscus Tear
Interventions: Procedure: Arthroscopic partial meniscectomy; Procedure: Sham procedure
Sponsors: Slagelse Hospital; Slagelse Hospital; University of Southern Denmark
Recruiting - verified November 2010 - Conditions: Obesity; Arthritis
Intervention: Drug: propofol or desflurane
Sponsors: Stanford University; Stanford University; Baxter Healthcare Corporation
Recruiting - verified July 2011 - Conditions: Idiopathic Bronchiectasis; Nontuberculous Mycobacterium (NTM) Infection
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Condition: Knee Osteoarthritis
Interventions: Behavioral: Tai Chi; Behavioral: Physical Therapy
Sponsors: Tufts Medical Center; Tufts Medical Center; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: Tocilizumab + methotrexate(MTX); Drug: Tocilizumab placebo + methotrexate(MTX)
Sponsors: Chugai Pharma Taiwan; Chugai Pharma Taiwan
Recruiting - verified April 2012 - Conditions: Ankylosing Spondylitis; Rheumatoid Arthritis
Intervention:
Sponsors: Far Eastern Memorial Hospital; Far Eastern Memorial Hospital
Recruiting - verified May 2012 - Condition: Osteoarthritis of the Knee
Interventions: Biological: Platelet Rich Plasma (Preparation Rich in Growth Factors); Drug: Hyaluronic acid
Sponsors: Meir Medical Center; Meir Medical Center
Not yet recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab
Sponsors: University Hospital, Tours; University Hospital, Tours
Recruiting - verified June 2011 - Conditions: Meniscus Tear; Chondropathy/Degenerative Joint Disease (DJD)
Interventions: Device: Euflexxa; Other: Saline
Sponsors: The Hawkins Foundation; The Hawkins Foundation; Ferring Pharmaceuticals
Recruiting - verified July 2011 - Conditions: Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa
Intervention: Genetic: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)
Sponsors: Stanford University; Stanford University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARD
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast; Drug: • Placebo
Sponsors: Celgene Corporation; Celgene Corporation
Recruiting - verified June 2011 - Condition: Osteoarthritis
Interventions: Procedure: OtisMed; Procedure: Computer Assisted Surgery (CAS)
Sponsors: Dalhousie University; Dalhousie University
Recruiting - verified March 2012 - Condition: Spondylitis, Ankylosing
Interventions: Biological: etanercept; Drug: Background NSAID; Other: PLACEBO; Drug: Background NSAID
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Osteoarthritis, Knee
Intervention: Other: Instrument
Sponsors: DePuy Orthopaedics; DePuy Orthopaedics
Recruiting - verified March 2012 - Conditions: Hip Osteoarthritis; Exercise; Hydrotherapy
Intervention: Other: Group training
Sponsors: Norwegian University of Science and Technology; Norwegian University of Science and Technology
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Schnitzler Syndrome
Intervention: Drug: Ilaris
Sponsors: Universitaire Ziekenhuizen Leuven; Universitaire Ziekenhuizen Leuven
Recruiting - verified November 2010 - Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib; Drug: Fostamatinib; Drug: Fostamatinib
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Osteoarthrosis Patients With Total Hip Arthroplasty
Intervention:
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital; Lundbeck Foundation
Recruiting - verified November 2010 - Condition: Osteoarthritis
Intervention: Device: Ceramic on metal articulating bearing surface
Sponsors: Biomet, Inc.; Biomet, Inc.
Recruiting - verified May 2012 - Condition: Knee Osteoarthritis
Interventions: Drug: Control; Drug: Etoricoxib
Sponsors: Singapore General Hospital; Singapore General Hospital; Merck
Not yet recruiting - verified June 2011 - Condition: Hand Osteoarthritis
Intervention: Other: Hand exercise program
Sponsors: Diakonhjemmet Hospital; Diakonhjemmet Hospital; Norwegian Fund for Postgraduate Training in Physiotherapy
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Other: Placebo, then certolizumab pegol (CZP); Biological: Certolizumab pegol (CZP)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Conditions: Primary Arthrosis; Post Traumatic Arthritis; Rheumatoid Arthritis; Osteoarthritis
Intervention: Device: Scandinavian Total Ankle Replacement System (STAR Ankle)
Sponsors: Small Bone Innovations, Inc.; Small Bone Innovations, Inc.
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified January 2012 - Condition: Primary Arthrosis
Intervention: Device: Scandinavian Total Ankle Replacement System (STAR Ankle)
Sponsors: Small Bone Innovations, Inc.; Small Bone Innovations, Inc.
Recruiting - verified March 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: CNTO 148 (Golimumab); Biological: CNTO 148 (golimumab) or placebo
Sponsors: Centocor, Inc.; Centocor, Inc.; Schering-Plough (Ireland) Company
Recruiting - verified May 2012 - Condition: Chronic Periodontitis
Intervention:
Sponsors: NHS South Birmingham; NHS South Birmingham; University of Birmingham
Not yet recruiting - verified July 2010 - Condition: Osteoarthritis (OA) of the Knee
Interventions: Drug: Triamcinolone Acetonide; Drug: 0.9% Sodium Chloride Injection as Placebo
Sponsors: Tufts Medical Center; Tufts Medical Center
Recruiting - verified March 2012 - Condition: HIV Infection
Intervention: Drug: Hydroxychloroquine
Sponsors: St Stephens Aids Trust; St Stephens Aids Trust
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: Milnacipran
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Forest Laboratories
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methylprednisolone
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention:
Sponsors: Heinrich-Heine University, Duesseldorf; Heinrich-Heine University, Duesseldorf
Recruiting - verified July 2011 - Conditions: Churg-Strauss Syndrome; Giant Cell Arteritis; Granulomatosis With Polyangiitis (Wegener's); Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu's Arteritis
Intervention:
Sponsors: Boston University; Boston University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Office of Rare Diseases (ORD); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Conditions: Depression; Asthma
Interventions: Drug: Escitalopram; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: LY2127399
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified October 2011 - Condition: Osteoarthritis of the Knee
Intervention: Device: Total Knee Arthroplasty
Sponsors: Smith & Nephew Orthopaedics AG; Smith & Nephew Orthopaedics AG
Recruiting - verified June 2011 - Condition: Osteoarthritis, Knee
Interventions: Biological: TissueGene-C; Drug: Normal Saline
Sponsors: TissueGene, Inc.; TissueGene, Inc.
Recruiting - verified June 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: Rituximab; Drug: Placebo
Sponsors: Johann Wolfgang Goethe University Hospitals; Johann Wolfgang Goethe University Hospitals
Recruiting - verified June 2011 - Condition: Arthritis, Rheumatoid
Intervention:
Sponsors: Biogen Idec; Biogen Idec; Crescendo
Recruiting - verified March 2012 - Condition: Arthritis
Interventions: Other: Blood samples; Other: Synovial fluid aspiration; Other: Synovial tissue sample
Sponsors: MedImmune LLC; MedImmune LLC; AstraZeneca
Recruiting - verified January 2012 - Conditions: Patients Age 20-90; Osteoarthritis
Intervention: Drug: Evicel fibrin sealant
Sponsors: Hospital for Special Surgery, New York; Hospital for Special Surgery, New York; Ethicon, Inc.
Recruiting - verified June 2011 - Condition: Knee Osteoarthritis
Interventions: Drug: Chondroitin sulphate (Condrosan®); Drug: Placebo
Sponsors: Bioiberica; Bioiberica
Recruiting - verified August 2011 - Condition: Arthritis, Rheumatoid
Interventions: Drug: Part 1: Etoricoxib 60 mg; Drug: Part 1: Etoricoxib 90 mg; Drug: Part 2: Etoricoxib 60 mg; Drug: Part 2: Etoricoxib 90 mg; Drug: Part 1: Placebo to Etoricoxib 60 mg; Drug: Part 1: Placebo to Etoricoxib 90 mg; Drug: Part 2: Placebo to Etoricoxib 60 mg; Drug: Part 2: Placebo to Etoricoxib 90 mg
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Arthritis, Rheumatoid
Intervention: Drug: Milnacipran
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Forest Laboratories; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Intervention: Drug: Rituximab
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Device: Ultrasonography
Sponsors: Diakonhjemmet Hospital; Espen A. Haavardsholm; The Research Council of Norway; Smerud Medical Research International AS; Oslo University Hospital, Section for GCP; Innovest; Abbott; UCB NORDIC A/S; Pfizer; MSD Norway AS; Roche Pharma AG; The Norwegian Rheumatism Association
Recruiting - verified April 2012 - Condition: Ankylosing Spondylitis(AS)
Interventions: Drug: Simponi; Other: 0.9ml sodium chloride
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong
Recruiting - verified February 2012 - Condition: Hip Arthritis
Interventions: Device: Hi-Fatigue Bone Cement; Device: Palacos Bone Cement
Sponsors: University of Aarhus; University of Aarhus; Aarhus University Hospital; Zimmer, Inc.
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Spondyloarthritis; Ultrasonography
Intervention: Biological: Anti-TNF alpha therapy
Sponsors: Diakonhjemmet Hospital; Diakonhjemmet Hospital
Not yet recruiting - verified September 2010 - Condition: Rheumatoid Arthritis
Interventions: Drug: LY2127399; Drug: Placebo every 2 weeks; Drug: Placebo every 4 weeks
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: fostamatinib; Drug: fostamatinib; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Spondylitis, Ankylosing
Interventions: Drug: Part I - etoricoxib 60 mg; Drug: Part I - etoricoxib 90 mg; Drug: Part I- naproxen 1000 mg; Drug: Part I - Placebo to etoricoxib 60 mg; Drug: Part I - Placebo to etoricoxib 90 mg; Drug: Part I - Placebo to naproxen 500 mg; Drug: Part II- etoricoxib 60 mg; Drug: Part II- etoricoxib 90 mg; Drug: Part II- naproxen 1000 mg; Drug: Part II - Placebo to etoricoxib 60 mg; Drug: Part II - Placebo to etoricoxib 90 mg; Drug: Part II - Placebo to naproxen 500 mg
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Osteoarthritis, Hip
Interventions: Other: Supervised progressive resistance training; Other: Control group
Sponsors: University of Aarhus; University of Aarhus; Regionshospitalet Silkeborg
Recruiting - verified November 2011 - Conditions: Arthritis, Rheumatoid; Pain; Fatigue
Interventions: Drug: adalimumab; Drug: Placebo
Sponsors: Karolinska Institutet; Karolinska Institutet; Abbott; Swedish Foundation for Strategic Research; The Swedish Research Council
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: apremilast; Other: Placebo
Sponsors: Baylor Research Institute; Baylor Research Institute
Recruiting - verified February 2012 - Condition: Acute Gout
Intervention: Drug: ACZ885
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Early Rheumatoid Arthritis
Interventions: Biological: adalimumab; Drug: methotrexate
Sponsors: Abbott; Abbott
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Humira (adalimumab); Drug: Methotrexate (MTX)
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Condition: Knee Osteoarthritis
Intervention:
Sponsors: Ulsan University Hospital; Ulsan University Hospital
Recruiting - verified December 2011 - Condition: Bariatric Surgery Candidate
Intervention: Other: knee MRI
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified May 2009 - Conditions: Osteoarthritis; Pain
Interventions: Behavioral: Tailored Activity Pacing; Behavioral: General Activity Pacing
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Condition: Post Streptococcal Reactive Arthritis
Intervention: Device: echocardiogram
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Other: randomisation
Sponsors: Universitaire Ziekenhuizen Leuven; P. Verschueren; Het agentschap voor Innovatie door Wetenschap en Technologie (IWT)
Recruiting - verified October 2011 - Condition: Osteoarthritis
Intervention: Device: Trabecular Metal Modular Tibial Total Knee Component
Sponsors: Dalhousie University; Dalhousie University; Zimmer, Inc.
Recruiting - verified January 2012 - Condition: Osteoarthritis
Intervention:
Sponsors: Smith & Nephew, Inc.; Smith & Nephew, Inc.; Jason Jones, MS, Group Director, Clinical Affairs, Smith&Nephew
Recruiting - verified August 2011 - Condition: Psoriasis
Intervention:
Sponsors: Rockefeller University; Rockefeller University; Weill Medical College of Cornell University
Recruiting - verified May 2012 - Condition: Myositis
Intervention: Procedure: Venepuncture
Sponsors: Salford Royal NHS Foundation Trust; Salford Royal NHS Foundation Trust
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Tasocitinib plus Methotrexate; Drug: Tasocitinib plus placebo methotrexate; Drug: Placebo tasocitinib plus Methotrexate
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Psoriatic Arthritis
Intervention: Biological: AIN457A
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Spondyloarthritis; Intestinal Inflammation
Intervention: Drug: Adalimumab
Sponsors: Regionshospitalet Silkeborg; Regionshospitalet Silkeborg; Abbott; European Capsule Endoscopy Group; The Central Denmark Region
Recruiting - verified July 2011 - Condition: Psoriasis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified January 2012 - Conditions: Osteoarthritis; Hip Arthroplasty
Intervention: Other: Preoperative resistance training
Sponsors: University of Southern Denmark; University of Southern Denmark; University of Copenhagen
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Diacerein; Drug: Placebo
Sponsors: TRB Chemedica; TRB Chemedica
Recruiting - verified October 2011 - Condition: Immune System
Intervention:
Sponsors: North Shore Long Island Jewish Health System; North Shore Long Island Jewish Health System; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); University of Alabama at Birmingham
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche; Clalit Health Services
Recruiting - verified May 2012 - Condition: Moderate to Severe Psoriasis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Condition: Osteoarthritis
Interventions: Drug: Hydroxychloroquine; Drug: cellulose
Sponsors: Maasstad Hospital; Maasstad Hospital
Recruiting - verified July 2011 - Conditions: Psoriatic Arthritis; Psoriasis
Intervention:
Sponsors: Innovaderm Research Inc.; Innovaderm Research Inc.; Amgen
Recruiting - verified October 2011 - Conditions: Genotype; Retinal Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified May 2011 - Conditions: Lyme Disease; Borrelia Burgdorferi
Interventions: Procedure: Skin Biopsy; Device: Xenodiagnosis; Procedure: Blood Drawing
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept; Drug: Methotrexate; Drug: Abatacept Placebo; Drug: Methotrexate Placebo
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Condition: Memory Impairment
Interventions: Drug: Lamotrigine; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Conditions: Rheumatoid Arthritis; Insulin Resistance
Intervention: Drug: Hydroxychloroquine
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2012 - Condition: Arthritis, Rheumatoid
Interventions: Biological: adalimumab; Drug: Methotrexate
Sponsors: Abbott; Abbott; Mount Sinai Hospital, Canada
Recruiting - verified December 2011 - Condition: Adhesive Capsulitis
Interventions: Procedure: isotonic saline injection into the glenohumeral joint; Procedure: steroid injection into the glenohumeral joint; Procedure: sodium hyaluronate injection into the glenohumeral joint; Procedure: steroid and hyaluronate injection into the glenohumeral joint; Procedure: intra-articular injection of the glenohumeral joint
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: APL A12
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Psoriatic Arthritis
Interventions: Drug: Methotrexate; Drug: Anti-TNF
Sponsors: University of Rochester; University of Rochester; National Psoriasis Foundation
Recruiting - verified October 2011 - Condition: Osteoarthritis
Intervention: Behavioral: Osteoarthritis Intervention
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott; University Health Network, Toronto
Recruiting - verified May 2012 - Conditions: Anakinra; Kineret; Atopic Dermatitis; Eczema; Allergic Disease
Intervention: Drug: Anakinra
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: abatacept; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN)
Recruiting - verified April 2012 - Condition: Osteoarthritis
Intervention: Device: iUni® Unicompartmental Knee Resurfacing Device
Sponsors: ConforMIS, Inc.; ConforMIS, Inc.
Recruiting - verified February 2012 - Conditions: Rheumatoid Arthritis; Cardiovascular Disease
Intervention:
Sponsors: University of Arkansas; University of Arkansas
Recruiting - verified December 2011 - Conditions: Osteoarthritis; Rheumatoid Arthritis
Interventions: Procedure: Minimally Invasive Anterior Approach; Procedure: Standard postero-lateral approach
Sponsors: Medacta International SA; Medacta International SA
Recruiting - verified January 2012 - Conditions: Osteoarthritis; Arthritis; Avascular Necrosis; Fracture of the Femoral Neck or Head; Congenital Hip Dysplasia
Intervention: Device: AMIStem Hip System
Sponsors: Medacta International SA; Medacta International SA
Recruiting - verified January 2012 - Conditions: Knee Pain; Osteoarthritis
Interventions: Device: Elf care; Other: control group
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Condition: Osteoarthritis of the Knee
Interventions: Biological: Apitox, purified honeybee toxin, lyophilized in saline; Biological: histamine
Sponsors: Apimeds, Inc.; Apimeds, Inc.
Not yet recruiting - verified September 2011 - Condition: Thumb Carpometacarpal Arthritis
Interventions: Procedure: Ligament reconstruction with suture fixation system; Procedure: Ligament Reconstruction with Tendon Interposition (LRTI)
Sponsors: J&M Shuler; J&M Shuler
Recruiting - verified June 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: Certolizumab
Sponsors: University of Rochester; University of Rochester
Recruiting - verified October 2011 - Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric PsoriasisCondition: Psoriasis
Intervention: Drug: Etanercept
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Ankylosing Spondylitis (AS) and Inadequate Response to ≥2 NSAIDs.
Intervention: Drug: Etoricoxib
Sponsors: Spanish Foundation of Rheumatology; Spanish Foundation of Rheumatology
Recruiting - verified October 2010 - Condition: Psoriasis
Intervention: Radiation: UVB-311nm radiation
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified April 2012 - Conditions: Psoriasis; Cardiovascular Diseases; Diabetes Mellitus, Type 2
Interventions: Drug: Adalimumab treatment arm; Drug: Fumaric acid esters treatment group; Other: Narrow band UVB radiation
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified January 2012 - Conditions: Crohn's Disease; Rheumatoid Arthritis
Intervention:
Sponsors: University of California, San Diego; University of California, San Diego; The Organization of Teratology Information Specialists; Abbott
Recruiting - verified April 2012 - Condition: Lupus Arthritis
Interventions: Drug: Laquinimod; Drug: Laquinimod; Other: Placebo
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: University of Rochester; University of Rochester
Recruiting - verified June 2011 - Conditions: Rheumatoid Arthritis; Osteoarthritis; Post-traumatic Arthritis; Avascular Necrosis; Traumatic Femoral Fractures; Congenital Hip Dysplasia
Intervention: Device: DePuy Proxima™ Hip
Sponsors: DePuy International; DePuy International
Recruiting - verified February 2012 - Condition: Autoimmune Disease
Intervention: Drug: Rituximab
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified January 2012 - Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis
Intervention: Biological: HUMIRA (adalimumab)
Sponsors: Abbott; Abbott; Veeda Clinical Research, Brussels
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Other: This is a non-drug study. No treatment is mandated by the protocol. Routine blood draws (as per normal clinical care) will be taken through the study.
Sponsors: Abbott; Abbott; Clinical Trial End-Point (CTEP) Ltd; JSS Medical Research Inc.
Recruiting - verified February 2012 - Conditions: Active Rheumatoid Arthritis; Osteoporoses
Intervention:
Sponsors: Abbott; Abbott; Centre of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Czech Republic
Recruiting - verified February 2012 - Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Not yet recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified January 2012 - Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeCondition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Condition: Arthritis, Rheumatoid
Interventions: Drug: Otelixizumab; Drug: Matching placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified November 2011 - Condition: Arthritis, Psoriatic
Interventions: Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: placebo; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: ustekinumab
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified April 2012 - Conditions: Anterior Cruciate Ligament Injury; Osteoarthritis
Interventions: Biological: MSB-CAR001 Combined With Hyaluronan; Drug: Hyaluronan
Sponsors: Mesoblast, Ltd.; Mesoblast, Ltd.
Recruiting - verified March 2010 - Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: rituximab [Mabthera/Rituxan]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: rituximab [Mabthera/Rituxan]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Joint Damage
Interventions: Drug: Febuxostat; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified March 2012 - Condition: Degenerative Arthritis of Knee
Interventions: Other: Total Knee Arthroplasty; Other: Total Knee Arthroplasty
Sponsors: Smith & Nephew, Inc.; Smith & Nephew, Inc.
Recruiting - verified November 2011 - Condition: Osteoarthritis, Knee
Intervention: Device: acupuncture
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Center for Complementary and Alternative Medicine (NCCAM); Harvard University; Brigham and Women's Hospital
Recruiting - verified February 2012 - Condition: Ankylosing Spondylitis
Intervention: Drug: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified February 2012 - Condition: Knee Osteoarthritis
Interventions: Dietary Supplement: Glucosamine sulphate; Other: Placebo
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified February 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Traumatic Arthritis
Interventions: Device: Vanguard CR; Device: AGC knee
Sponsors: Biomet, Inc.; Biomet, Inc.; Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK); Biomet U.K. Ltd.
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: SAR153191 (REGN88); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Traumatic Arthritis; Avascular Necrosis
Intervention: Device: Tritanium® Acetabular Shell
Sponsors: Stryker Orthopaedics; Stryker Orthopaedics
Recruiting - verified May 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention: Drug: anti-TNF therapy (etanercept or adalimumab)
Sponsors: Imperial College London; Imperial College London
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: AMG 827
Sponsors: Amgen; Amgen
Not yet recruiting - verified July 2011 - Condition: Osteoarthritis of the Hip or Knee
Interventions: Drug: Dexibuprofen; Drug: Ibuprofen
Sponsors: Gebro Pharma GmbH; Gebro Pharma GmbH
Recruiting - verified March 2012 - Condition: Osteoarthritis, Hip
Intervention:
Sponsors: Smith & Nephew, Inc.; Smith & Nephew, Inc.
Recruiting - verified July 2011 - Condition: Osteoarthritis, Hip
Intervention:
Sponsors: Smith & Nephew, Inc.; Smith & Nephew, Inc.
Recruiting - verified July 2011 - A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid ArthritisCondition: Rheumatoid Arthritis
Interventions: Drug: CAM3001; Drug: CAM3001; Drug: CAM3001; Drug: CAM3001
Sponsors: MedImmune LLC; MedImmune LLC; MedImmune Ltd
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Other: MRI
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Recruiting - verified December 2011 - Condition: Osteoarthritis
Interventions: Other: Group Physical Therapy for Knee OA; Other: Individual Physical Therapy for Knee OA
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Condition: Polyarthritis
Interventions: Drug: Methotrexate; Drug: Placebo
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Recruiting - verified December 2011 - Condition: Breast Cancer
Interventions: Other: History and Physical Exam; Other: Grip Strength Measurement; Behavioral: Surveys; Other: Blood Collection; Procedure: Ultrasound of Hand/Wrist
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified February 2012 - Conditions: Osteoarthritis of the Knee; Arthroscopy; Meniscal Tear
Interventions: Procedure: Arthroscopic partial meniscectomy; Procedure: Arthroscopy (diagnostic)
Sponsors: University of Tampere; University of Tampere; Helsinki University Central Hospital; Turku University Hospital; Kuopio University Hospital; Central Finland Hospital District
Recruiting - verified January 2012 - Conditions: Osteoarthritis, Knee; Osteonecrosis
Intervention:
Sponsors: AO Clinical Investigation and Documentation; AO Clinical Investigation and Documentation; Synthes Inc.
Recruiting - verified October 2011 - Condition: Acromioclavicular Joint Arthritis
Intervention: Procedure: distal clavicle resection
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified June 2011 - Conditions: Crohn's Disease; Ulcerative Colitis
Interventions: Drug: smoking of cannabis; Drug: smoking cigarettes with placebo
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: CF101; Drug: Placebo control
Sponsors: Can-Fite BioPharma; Can-Fite BioPharma
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: placebo TCZ; Drug: placebo MTX
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: non-biological DMARDs
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified December 2011 - Conditions: Osteoarthritis; Knee Replacement
Intervention:
Sponsors: Coxa, Hospital for Joint Replacement; Coxa, Hospital for Joint Replacement; University of Tampere; Seinajoki Central Hospital
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: Adalimumab
Sponsors: Glostrup University Hospital, Copenhagen; Glostrup University Hospital, Copenhagen
Recruiting - verified March 2012 - Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With SpondyloarthritisCondition: Spondyloarthritis
Interventions: Drug: Adalimumab; Drug: Placebo
Sponsors: Glostrup University Hospital, Copenhagen; Glostrup University Hospital, Copenhagen
Recruiting - verified March 2012 - Conditions: Pain; Weakness; Cramps; Myalgia; Side Effects of Statins
Interventions: Dietary Supplement: Coenzyme Q10; Other: Placebo
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified June 2011 - Condition: Osteoarthritis
Interventions: Procedure: Mini-Posterior surgical approach for total hip arthroplasty; Procedure: Direct Anterior surgical approach for total hip arthroplasty
Sponsors: OrthoCarolina Research Institute, Inc.; OrthoCarolina Research Institute, Inc.
Recruiting - verified January 2012 - Conditions: HIV Infection; Osteopenia; Osteoporosis
Intervention:
Sponsors: Emory University; Emory University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified March 2012 - Condition: Acute Arthritis
Intervention:
Sponsors: University Hospital, Grenoble; University Hospital, Grenoble
Recruiting - verified December 2011 - Condition: Active Rheumatoid Arthritis
Intervention: Drug: SBI-087
Sponsors: Pfizer; Pfizer; Emergent Product Development Seattle LLC
Recruiting - verified April 2012 - Conditions: Breast Cancer; Recurrent Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer
Interventions: Procedure: acupuncture therapy; Procedure: sham intervention
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified May 2012 - Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque PsoriasisConditions: Arthritis, Psoriatic; Psoriasis
Intervention: Other: questionnaire
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Osteoarthritis
Interventions: Device: Cormet; Device: Conserve
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Corin
Recruiting - verified December 2011 - Condition: Unstable Lisfranc Fracture-dislocations of the Midfoot
Interventions: Procedure: Steel screw fixation of Lisfranc fracture-dislocation.; Procedure: Absorbable screw fixation of Lisfranc fracture-dislocations.
Sponsors: Rothman Institute Orthopaedics; Rothman Institute Orthopaedics
Recruiting - verified July 2011 - Condition: Osteoarthritis, Knee
Interventions: Procedure: TKA surgery with modular polished tibial baseplate/XLK design; Procedure: TKA surgery with the nonmodular APT/GVF design; Device: P.F.C.® Sigma Knee System; Device: P.F.C.® Sigma Knee System
Sponsors: Minneapolis Veterans Affairs Medical Center; Minneapolis Veterans Affairs Medical Center (VAMC); Depuy, Inc.
Recruiting - verified July 2011 - Condition: Non-small Cell Lung Cancer
Interventions: Drug: Erlotinib; Drug: Hydroxychloroquine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Stanford University; Yale University; University of Maryland; Genentech
Recruiting - verified April 2012 - Conditions: Chronic Allograft Nephropathy; Chronic Kidney Disease; Chronic Renal Failure; Disordered Mineral Metabolism; End Stage Renal Disease; Hyperparathyroidism; Hypophosphatemia; Kidney Disease; Kidney Transplantation; Post Renal Transplantation
Interventions: Drug: Cinacalcet; Drug: Placebo
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: First MTP Joint Osteoarthritis
Interventions: Device: Arthrodesis; Device: Cartiva
Sponsors: Carticept Medical, Inc; Carticept Medical, Inc
Recruiting - verified August 2011 - Condition: Arthropathy of Knee Joint
Interventions: Procedure: Total Knee Arthroplasty; Procedure: Motion analysis
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Wright Medical Technology
Not yet recruiting - verified December 2011 - Condition: Bradycardia
Intervention: Other: Fill out Questionnaire
Sponsors: Medtronic Bakken Research Center; Medtronic Bakken Research Center
Recruiting - verified January 2012 - Condition: Osteoarthritis
Interventions: Procedure: Anterior Approach; Procedure: Posterior Approach
Sponsors: Medacta USA; Medacta USA; Medacta International SA
Recruiting - verified November 2011 - Conditions: Osteoarthritis, Knee; Obesity
Intervention: Dietary Supplement: day formula diet
Sponsors: Frederiksberg University Hospital; Henning Bliddal; Velux Fonden; Oak Foundation; The Danish Rheumatism Association; Cambridge Health & Weight Plan, UK
Recruiting - verified January 2012 - Condition: Schnitzler Syndrome
Intervention:
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Other: Neuromuscular electrical stimulation; Other: Volitional exercises
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified September 2011 - Conditions: Hip Joint; Osteoarthritis; Arthroplasty
Interventions: Device: A Class BFH; Device: Metal on Polyethylene
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Wright Medical Technology
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Methotrexate; Drug: Infliximab
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong
Recruiting - verified February 2012 - Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Endothelial Dysfunction; Inflammatory Disease Activity
Intervention:
Sponsors: Revmatismesykehuset AS; Revmatismesykehuset AS; Abbott
Recruiting - verified May 2009 - Condition: Osteoarthritis, Knee
Intervention: Device: Knee arthroplasty
Sponsors: University of Aarhus; University of Aarhus; Stryker Nordic; DePuy Orthopaedics
Recruiting - verified March 2012 - Conditions: Psoriasis; Coronary Artery Disease
Intervention: Procedure: CCTA Scan (Coronary CT Angiogram)
Sponsors: University of Michigan; University of Michigan
Recruiting - verified August 2011 - Condition: Knee Osteoarthritis
Interventions: Other: preoperative neuromuscular training; Behavioral: knee OA School
Sponsors: University of Zurich; University of Zurich; Kantonsspital Olten; Kantonsspital Aarau; Lund University; Maastricht University
Recruiting - verified October 2011 - Condition: Sarcopenia
Interventions: Drug: Rapamycin; Other: Amino acid supplementation; Other: Low-intensity resistance exercise; Drug: Sodium nitroprusside; Device: Blood flow restriction cuff; Other: Low-intensity resistance exercise
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Condition: Urticaria
Intervention: Drug: abatacept (Orencia ®)
Sponsors: Johns Hopkins University; Johns Hopkins University; Bristol-Myers Squibb
Recruiting - verified October 2011 - Condition: Adhesive Capsulitis
Intervention: Device: Dynasplint
Sponsors: Dynasplint Systems, Inc.; Dynasplint Systems, Inc.
Recruiting - verified April 2012 - Condition: HIV Infection
Intervention: Drug: All licensed antiretroviral medications
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID); Copenhagen HIV Programme (CHIP) -- Copenhagen, Denmark; Medical Research Council (MRC) Clinical Trials Unit -- London, United Kingdom; Kirby Institute; The Institute for Clinical Research at the Veterans Affairs Medical Center -- Washington, D.C., USA; French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); German Federal Ministry of Education and Research; NEAT - European AIDS Treatment Network; National Health and Medical Research Council, Australia; National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Mental Health (NIMH); National Institute of Neurological Disorders and Stroke (NINDS); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Abbott; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck; Tibotec Pharmaceutical Limited
Recruiting - verified April 2012 - Condition: Osteoarthritis, Knee
Interventions: Other: Periosteal stimulation; Other: Control-Periosteal Stimulation
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Obesity
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Conditions: Osteoarthritis; Traumatic Arthritis; Avascular Necrosis of the Femoral Condyle; Moderate Varus; Valgus; Flexion Deformities
Intervention: Device: NexGen LPS-Flex Mobile Bearing Knee
Sponsors: Zimmer, Inc.; Zimmer, Inc.
Recruiting - verified April 2012 - Conditions: Polymyalgia Rheumatica; Rheumatoid Arthritis; Rheumatic Disease
Intervention:
Sponsors: Lahey Clinic; Lahey Clinic
Recruiting - verified February 2012 - Condition: Scoliosis
Interventions: Procedure: Surgical intervention; Other: Non operative intervention
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Northwestern University; New York University; University of Virginia; University of Louisville; Maryland Spine Center; Hospital for Special Surgery, New York; University Health Network, Toronto; Hopital du Sacre', Montreal University; Dartmouth-Hitchcock Medical Center
Recruiting - verified April 2012 - Condition: Osteoarthritis, Knee
Interventions: Radiation: MRI; Procedure: Primary Total Knee Replacement
Sponsors: The New England Baptist Hospital; The New England Baptist Hospital; Genzyme
Recruiting - verified June 2011 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis
Interventions: Procedure: Navigated TKA with a minimally invasive approach; Procedure: Navigated TKA with a conventional approach
Sponsors: Aesculap AG; Aesculap AG
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: Adalimumab
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: Chronic Sinusitis; Rhinosinusitis; Nasal Polyps
Intervention: Drug: Prednisone
Sponsors: Northwestern University; Northwestern University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Condition: Adhesive Capsulitis
Interventions: Drug: lidocaine; Drug: triamcinolone
Sponsors: Oslo University Hospital; Oslo University Hospital
Recruiting - verified June 2011 - Condition: Osteoarthritis of the Knee
Interventions: Drug: CF101; Drug: Placebo
Sponsors: Can-Fite BioPharma; Can-Fite BioPharma
Not yet recruiting - verified February 2012 - Conditions: Juvenile Idiopathic Arthritis; Systemic Lupus Erythematosus; Juvenile Dermatomyositis
Intervention: Drug: Human papilloma virus vaccine (cervarix)
Sponsors: UMC Utrecht; N.M. Wulffraat; National Institute for Public Health and the Environment (RIVM)
Recruiting - verified August 2011 - Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib; Drug: Naproxen
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Other: Withdrawal of anti-TNF therapy
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: adalimumab; Drug: Methotrexate
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Osteoarthritis
Interventions: Dietary Supplement: Essential amino acids; Dietary Supplement: Alanine
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2012 - Conditions: Osteoarthritis; Avascular Necrosis; Traumatic Arthritis; Rheumatoid Arthritis
Intervention: Procedure: metal on metal hip arthroplasty
Sponsors: Biomet, Inc.; Biomet, Inc.; Biomet U.K. Ltd.
Not yet recruiting - verified May 2012 - Condition: Femoral Neck Fractures
Interventions: Device: Open reduction internal fixation (ORIF) with single sliding hip screw; Device: ORIF with multiple cancellous screws
Sponsors: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Canadian Institutes of Health Research (CIHR); Stichting Nuts Ohra (SNO); Physicians Services Incorporated (PSI) Foundation
Recruiting - verified April 2012 - Condition: Arthritis, Rheumatoid
Interventions: Procedure: Laser Based Photoacoustic Tomography, MRI, Ultrasound; Procedure: laser based photoacoustic tomography, MRI, ultrasound
Sponsors: University of Michigan; University of Michigan
Recruiting - verified May 2012 - Condition: Systemic Lupus Erythematosus
Intervention:
Sponsors: Medical University of South Carolina; Medical University of South Carolina; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified August 2011 - Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic
Intervention:
Sponsors: Janssen Inc.; Janssen Inc.
Recruiting - verified May 2012 - Condition: Takayasu Arteritis
Intervention:
Sponsors: Boston University; Peter A. Merkel; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Osteoarthritis
Interventions: Device: Uniglide Mobile Bearing Unicondylar Knee System; Device: Uniglide Fixed Bearing Unicondylar Knee System
Sponsors: Corin; Corin
Recruiting - verified June 2011 - Conditions: Chronic Pain; Osteoarthritis
Intervention: Drug: MS Contin
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Nursing Research (NINR)
Recruiting - verified June 2011 - Condition: SPONDYLOARTHRITIS
Intervention: Drug: Discontinuation of TNF-alpha inhibitor and re-starting it if flare-up in disease activity (etanercept or adalimumab)
Sponsors: Glostrup University Hospital, Copenhagen; Glostrup University Hospital, Copenhagen
Recruiting - verified March 2012 - Conditions: Crohn Disease; Arthritis, Rheumatoid
Intervention:
Sponsors: Janssen Inc.; Janssen Inc.
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Avascular Necrosis; Rheumatoid Arthritis
Intervention: Device: Cormet Hip Resurfacing
Sponsors: Corin; Corin
Recruiting - verified June 2011 - Conditions: Crohn's Disease; Ankylosing Spondylitis
Intervention: Biological: Infliximab
Sponsors: Janssen Korea, Ltd., Korea; Janssen Korea, Ltd., Korea
Recruiting - verified August 2011 - Condition: Osteoarthritis
Intervention: Device: Total shoulder arthroplasty (Global® AP™ Shoulder)
Sponsors: DePuy Orthopaedics; DePuy Orthopaedics
Recruiting - verified April 2012 - Condition: Total Hip Replacement (Non-inflammatory)
Intervention: Device: Novation Ceramic
Sponsors: Exactech; Exactech
Recruiting - verified November 2011 - Condition: Osteoarthritis, Carpometacarpal
Interventions: Device: Comfort Cool thumb splint by North Coast Medical; Device: Custom made thermoplastic & neoprene splint
Sponsors: University of British Columbia; University of British Columbia; Vancouver Foundation
Recruiting - verified April 2012 - Condition: Osteoarthritis, Knee
Interventions: Device: Oxford Uni Knee; Device: Oxford Uni Knee; Device: Oxford Uni Knee
Sponsors: University of Aarhus; University of Aarhus; Aarhus University Hospital; Vejle Hospital; Biomet, Inc.
Recruiting - verified March 2012 - Condition: Hip Arthritis
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute
Recruiting - verified October 2011 - Condition: Joint Disease
Interventions: Procedure: LRTI; Procedure: Ascension PyroDisk
Sponsors: Simon Fraser Orthopaedic Fund; Simon Fraser Orthopaedic Fund
Recruiting - verified June 2011 - Condition: Sciatica
Interventions: Drug: Prednisone; Drug: Placebo
Sponsors: Kaiser Permanente; Kaiser Permanente; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Arthroplasty; Hip Replacement
Interventions: Procedure: Motion analysis; Procedure: Motion analysis; Procedure: Motion analysis
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Shoulder Capsulitis
Interventions: Procedure: infiltration intra articular; Procedure: ARTHRO distension plus intensive mobilisation
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified May 2008 - Condition: Rheumatoid Arthritis
Intervention: Drug: CP-690,550
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Arthritis
Intervention: Device: Birmingham Hip Resurfacing System
Sponsors: Smith & Nephew, Inc.; Smith & Nephew, Inc.
Recruiting - verified November 2011 - Condition: Osteoarthritis
Intervention: Other: Knee muscle exercises
Sponsors: Jyväskylä Central Hospital; Jyväskylä Central Hospital
Recruiting - verified February 2012 - Condition: Knee Osteoarthritis
Intervention: Dietary Supplement: Vitamin D3 (cholecalciferol)
Sponsors: University of Zurich; University of Zurich; Harvard School of Public Health; Tufts University; Boston University
Recruiting - verified December 2011 - Condition: Pelvic Fracture
Interventions: Drug: Teriparatide; Drug: Placebo
Sponsors: University of Rochester; University of Rochester; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institutes of Health (NIH)
Recruiting - verified January 2012 - Conditions: Arthritis; Avascular Necrosis
Intervention: Device: ReCap Total Hip Resurfacing System
Sponsors: Biomet, Inc.; Biomet, Inc.
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan]; Drug: Methotrexate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified January 2012 - Condition: Arthritis
Interventions: Biological: Gardasil; Biological: Gardasil; Biological: Gardasil
Sponsors: University Hospitals of Cleveland; University Hospitals of Cleveland; Merck
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: pioglitazone
Sponsors: University of Michigan; University of Michigan; National Institutes of Health (NIH)
Recruiting - verified October 2011 - Condition: Ankle Arthritis
Interventions: Procedure: Ankle Arthroplasty; Procedure: Ankle Arthrodesis
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Canadian Orthopaedic Foot and Ankle Society; Johnson & Johnson
Recruiting - verified May 2009 - Conditions: Osteoarthritis of Hip; Traumatic Arthritis of Hip
Intervention: Procedure: Hip replacement
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Biomet, Inc.
Recruiting - verified June 2011 - Conditions: Hip Fractures; Femoral Neck Fractures
Interventions: Device: Total hip arthroplasty; Device: Hemi-arthroplasty
Sponsors: Boston University; Boston University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Hamilton Health Sciences Corporation; ZonMw: The Netherlands Organisation for Health Research and Development; Canadian Institutes of Health Research (CIHR)
Recruiting - verified October 2011 - Conditions: Osteoarthritis of Hip; Traumatic Arthritis of Hip
Intervention: Procedure: Total Hip Arthroplasty
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Biomet, Inc.
Recruiting - verified June 2011 - Conditions: Purpura, Thrombocytopenic, Idiopathic; Autoimmune Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Autoimmune
Intervention: Biological: veltuzumab
Sponsors: Immunomedics, Inc.; Immunomedics, Inc.
Recruiting - verified January 2012 - Condition: Ankylosing Spondylitis
Intervention: Drug: Etanercept
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Psoriasis; Arthritis, Psoriatic
Interventions: Biological: ustekinumab; Biological: Biological therapies other than infliximab and ustekinumab; Drug: conventional systemic agents; Biological: infliximab
Sponsors: Centocor Ortho Biotech Services, L.L.C.; Centocor Ortho Biotech Services, L.L.C.
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-Traumatic Arthritis; Septic Arthritis; Prior Ankle Fusion
Intervention: Device: ankle joint replacement
Sponsors: Tornier; Tornier
Recruiting - verified June 2010 - Conditions: Pulmonary Hypertension; Connective Tissue Disease
Intervention: Behavioral: exercise training
Sponsors: University of Heidelberg; University of Heidelberg
Recruiting - verified March 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsors: University of Alberta; University of Alberta; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Condition: Antiphospholipid Syndrome
Intervention:
Sponsors: Duke University; Duke University
Recruiting - verified August 2011 - Conditions: Osteoarthritis; Rheumatoid Arthritis
Interventions: Drug: Celecoxib; Drug: non-selective Non steroidal anti inflammatory Drug
Sponsors: University of Dundee; University of Dundee; University of Glasgow; University of Nottingham
Recruiting - verified May 2012 - Condition: Osteoarthritis of the Hip
Intervention: Procedure: -preoperative education and total hip replacement
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Cochin Hospital
Recruiting - verified March 2007 - Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Osteosarcoma; Scoliosis; Cerebral Palsy
Intervention:
Sponsors: University of Florida; University of Florida
Recruiting - verified April 2012 - Condition: Osteoarthritis
Intervention: Procedure: Copeland or Global CAP resurfacing prosthesis
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified March 2012 - Condition: Lumbar Spinal Stenosis
Interventions: Device: ACADIA® Facet Replacement System; Device: Instrumented posterolateral fusion
Sponsors: Globus Medical Inc; Globus Medical Inc
Recruiting - verified April 2012 - Condition: Knee Osteoarthritis
Intervention: Procedure: Pharmacist-Initiated Intervention in OsteoArthritis (PhIT-OA)
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR); Canadian Arthritis Network; Michael Smith Foundation for Health Research
Not yet recruiting - verified November 2011 - Conditions: Autoimmune Pancytopenia; Autoimmune Lymphoproliferative Syndrome (ALPS); Evans Syndrome; Idiopathic Thrombocytopenic Purpura; Anemia, Hemolytic, Autoimmune; Autoimmune Neutropenia; Lupus Erythematosus, Systemic; Inflammatory Bowel Disease; Rheumatoid Arthritis
Intervention: Drug: sirolimus
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia
Recruiting - verified May 2012 - Condition: Osteoarthritis
Intervention: Procedure: Gait analysis
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Orthopaedic Associates of Michigan, PC; Orthopedic + Fracture Specialists (Portland, OR); Minnesota Orthopedic Sports Medicine Institute Twin Cities Orthopedics (Edina, MN)
Recruiting - verified May 2012 - Conditions: Arthritis, Rheumatoid; Osteoarthritis
Interventions: Drug: celecoxib; Drug: Ibuprofen; Drug: Naproxen
Sponsors: Pfizer; Pfizer; The Cleveland Clinic
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Radboud University; Radboud University
Recruiting - verified November 2011 - Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Wegener's
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Churg-Strauss Syndrome
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Polyarteritis Nodosa
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Takayasu's Arteritis
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Temporal Arteritis
Intervention:
Sponsors: Boston University; Peter A. Merkel; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Lovastatin; Device: Lovastatin placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Autoimmunity Centers of Excellence
Recruiting - verified September 2011 - Conditions: Leukoplakia, Oral; Benign Neoplasms
Interventions: Drug: sulindac; Drug: Placebo
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Amrita Institute of Sciences, AIMS, Cochin, India; Weill Medical College of Cornell University; Regional Cancer Center(RCC), Trivandrum, India; Narayana Hrudayalaya Hospitals
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: Hematopoietic Stem Cell Transplantation
Sponsors: Northwestern University; Richard Burt, MD
Recruiting - verified April 2012 - Condition: Prostate Cancer
Interventions: Drug: celecoxib; Drug: docetaxel; Drug: prednisolone; Drug: releasing hormone agonist therapy; Drug: zoledronic acid; Drug: abiraterone; Procedure: orchiectomy
Sponsors: Medical Research Council; Medical Research Council
Recruiting - verified March 2012 - Conditions: Rotator Cuff Tear; Osteoarthritis; Shoulder Instability
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified August 2011 - Conditions: Relapsed or Refractory Severe Aplastic Anemia; Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath(Registered Trademark))
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Conditions: Systemic Lupus Erythematosus; Antiphospholipid Syndrome
Intervention:
Sponsors: Hospital for Special Surgery, New York; Hospital for Special Surgery, New York; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified December 2011 - Condition: Vasculitis
Intervention: Drug: azathioprine
Sponsors: University Medical Centre Groningen; University Medical Centre Groningen; ZonMw: The Netherlands Organisation for Health Research and Development; Dutch Arthritis Association; Dutch Kidney Foundation
Recruiting - verified November 2011 - Condition: Spondylitis, Ankylosing
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified January 2012 - Conditions: Nervous System Malformations; Arthropathy, Neurogenic; Urticaria; Papilledema
Intervention: Drug: Anakinra
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified November 2011 - Conditions: Urticaria; Arthropathy; Lymphadenopathy; Nervous System Anomalies
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified January 2012 - Condition: Ankylosing Spondylitis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2012 - Conditions: Rheumatic Diseases; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Scleroderma; Dermatomyositis; Myositis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified November 2011 - Conditions: Rheumatic Diseases; Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified January 2012 - Condition: Rheumatic Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified October 2011 - Condition: Hemochromatosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Recruiting - verified August 2011 - Conditions: Arthritis; Synovitis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified October 2011 - Condition: Alkaptonuria
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified February 2012 - Conditions: Chronic Disease; Healthy; Lyme Arthritis; Lyme Disease; Multiple Sclerosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Conditions: Sjogren's Syndrome; Xerostomia
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified October 2011 - Condition: Immunologic Deficiency Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified October 2011 - Conditions: Lupus Nephritis; Systemic Lupus Erythematosus
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified January 2012 - Conditions: Autoimmune Disease; Dermatomyositis; Inclusion Body Myositis; Myositis; Polymyositis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified August 2011 - Conditions: Healthy; Immunologic Deficiency Syndrome; Job's Syndrome; Severe Combined Immunodeficiency
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Condition: HIV Infection
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID); Washington Hospital Center
Recruiting - verified January 2012 - Condition: Periodic Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2012
 |
Join Clinical Trials in Sitka,Alaska |
